<SEC-DOCUMENT>0001178913-21-003302.txt : 20211029
<SEC-HEADER>0001178913-21-003302.hdr.sgml : 20211029
<ACCEPTANCE-DATETIME>20211029163230
ACCESSION NUMBER:		0001178913-21-003302
CONFORMED SUBMISSION TYPE:	6-K/A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20211029
FILED AS OF DATE:		20211029
DATE AS OF CHANGE:		20211029

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Check-Cap Ltd
		CENTRAL INDEX KEY:			0001610590
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3

	FILING VALUES:
		FORM TYPE:		6-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36848
		FILM NUMBER:		211363748

	BUSINESS ADDRESS:	
		STREET 1:		ABBA HUSHI AVENUE
		STREET 2:		P.O. BOX 1271
		CITY:			ISFIYA
		STATE:			L3
		ZIP:			3009000
		BUSINESS PHONE:		972-4-8303400

	MAIL ADDRESS:	
		STREET 1:		ABBA HUSHI AVENUE
		STREET 2:		P.O. BOX 1271
		CITY:			ISFIYA
		STATE:			L3
		ZIP:			3009000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K/A
<SEQUENCE>1
<FILENAME>zk2126718.htm
<DESCRIPTION>6-K/A
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.6.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div style="text-align: center; line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">UNITED STATES</div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Washington, DC 20549</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">
        <div style="margin-left: 3.1pt; line-height: 1.25; font-weight: bold;">Form 6-K/A</div>
        <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(Amendment No. 1)</div>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">PURSUANT TO RULE&#160;13a-16 OR 15d-16 UNDER</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">THE SECURITIES EXCHANGE ACT OF 1934</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">For October 2021</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">Commission File No.&#160;001-36848</div>
      <div style="line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25; font-size: 16pt;">
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Check-Cap Ltd.
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160; Check-Cap Building</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Abba Hushi Avenue</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">P.O. Box 1271</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Isfiya, 30090</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Mount Carmel, Israel</div>
      <div style="text-align: center; line-height: 1.25;">(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES.)</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</div>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">Form 20-F&#160;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Form 40-F&#160;<font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">This exhibits attached to this Form 6-K are hereby incorporated by reference into the Post-Effective Amendment No. 1 to the Form S-8 Registration Statement File No. 333-203384,
        Form S-8 Registration Statement File No. 333-226490, and into the Form F-3 Registration Statements File Nos. 333-211065 and 333-225789.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Other Information</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">On October 21, 2021, Check-Cap Ltd. (the &#8220;Company&#8221;) filed a Current Report on Form 6-K announcing that it will hold an Annual
          Meeting of Shareholders on December 2, 2021 at 4:00 p.m. (Israel time) at the Company&#8217;s offices 29 Abba Hushi Avenue, Isfiya, Israel and attached a Notice and Proxy Statement and a Proxy Card.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">This Amendment No. 1 on Form 6-K/A is being furnished to amend and restate the Proxy Card in order to amend items 3A and 3B to
          the Proxy Card.&#160; A copy of the Notice of the 2021 Annual General Meeting of Shareholders and Proxy Statement and the Proxy Card are attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and are incorporated herein by reference.</div>
      </div>
      <div style="line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 10.64%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Exhibit</div>
            </td>
            <td style="width: 2.48%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 86.88%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10.64%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 2.48%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 86.88%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10.64%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Exhibit No</font>.&#160;</div>
            </td>
            <td style="width: 2.48%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 86.88%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Description</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10.64%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 2.48%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 86.88%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10.64%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_99-1.htm">99.1</a></div>
            </td>
            <td style="width: 2.48%; vertical-align: top;">&#160;</td>
            <td style="width: 86.88%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_99-1.htm">Notice and Proxy Statement for the 2021 Annual General Meeting of
                  Shareholders</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 10.64%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 2.48%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 86.88%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10.64%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321003214/exhibit_99-2.htm">99.2</a></div>
            </td>
            <td style="width: 2.48%; vertical-align: top;">&#160;</td>
            <td style="width: 86.88%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;"><a href="https://www.sec.gov/Archives/edgar/data/1610590/000117891321003214/exhibit_99-2.htm">Proxy Card</a></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; line-height: 1.25;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>SIGNATURES</u></div>
      <div style="text-align: center; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
        authorized.</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 49.93%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 27.13%; vertical-align: top;" colspan="2">
              <div style="line-height: 1.25;">Check-Cap Ltd.</div>
            </td>
            <td style="width: 22.93%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.93%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3.2%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 23.93%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 22.93%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.93%; vertical-align: middle;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3.2%; vertical-align: top;">
              <div style="line-height: 1.25;">By:</div>
            </td>
            <td style="width: 23.93%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="line-height: 1.25;">/s/ Alex Ovadia</div>
            </td>
            <td style="width: 22.93%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.93%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3.2%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 23.93%; vertical-align: top;">
              <div style="line-height: 1.25;">Name: Alex Ovadia</div>
            </td>
            <td style="width: 22.93%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.93%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;Date: October 29, 2021</div>
            </td>
            <td style="width: 3.2%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 23.93%; vertical-align: top;">
              <div style="line-height: 1.25;">Title: Chief Executive Officer</div>
            </td>
            <td style="width: 22.93%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: 36pt; line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.6.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div id="DSPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
    <div style="line-height: 1.25; text-align: right;"><u><font style="font-weight: bold;">Exhibit 99.1</font></u><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; text-align: center;">&#160;<img src="image00002.jpg"></div>
    <div style="text-align: center; line-height: 1.25;"></div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Check-Cap Ltd.</div>
    <div style="text-align: center; line-height: 1.25;">Check-Cap Building</div>
    <div style="text-align: center; line-height: 1.25;">29 Abba Hushi Avenue</div>
    <div style="text-align: center; line-height: 1.25;">P.O. Box 1271</div>
    <div style="text-align: center; line-height: 1.25;">Isfiya, 3009000</div>
    <div style="text-align: center; line-height: 1.25;">Israel</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">NOTICE OF 2021 ANNUAL GENERAL MEETING OF SHAREHOLDERS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Dear Shareholder:</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25"> We cordially invite you to attend the 2021 Annual General Meeting of Shareholders of Check-Cap Ltd. (the &#8220;Meeting&#8221;) to be held on Thursday, December 2, 2021, at 4:00 p.m. (Israel time) at our offices at the Check-Cap
      Building, 29 Abba Hushi Avenue, P.O. Box 1271, Isfiya, 3009000, Israel, for the following purposes:</div>
    <div style="line-height: 1.25"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>To re-elect all five directors to serve as members of our Board of Directors, until our next annual general meeting of shareholders and until their respective successors are duly elected;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>To approve the remuneration to be paid to each of the director nominees, subject to their re-election at the Meeting;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>To approve amended annual bonus terms for Mr. Alex Ovadia, our Chief Executive Officer, and a one-time award of options to Mr. Ovadia;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>To ratify and approve the reappointment of Brightman Almagor Zohar &amp; Co., Certified Public Accountants, a firm in the Deloitte Global Network, as our independent auditor for the year ending December 31, 2021 and for such additional
              period until our next annual general meeting; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>To review and discuss our financial statements for the year ended December 31, 2020.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are currently not aware of any other matters that will come before the Meeting.&#160; If any other matters are presented properly at the Meeting, the persons designated as proxies
      intend to vote upon such matters in accordance with their best judgment.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Only shareholders of record at the close of business on October 26, 2021, are entitled to notice of and to vote at the Meeting or at any adjournment thereof.&#160; You can vote either
      by mailing in your proxy or in person by attending the Meeting.&#160; Proxies must be received by our transfer agent or at our registered office in Israel no later than forty-eight (48) hours prior to the designated time for the Meeting.&#160; Proxies received
      by our transfer agent or at our registered office in Israel during the forty-eight (48) hours preceding the designated time for the Meeting will be presented to the Chairman of the Meeting and, at his discretion, may be voted as specified in the
      instructions included in such proxies.&#160; If you attend the Meeting, you may vote in person and your proxy will not be used.&#160; If you are a beneficial owner of shares registered in the name of your broker, bank, trustee or nominee and you wish to vote
      in person at the Meeting, you must first obtain a &#8220;legal proxy&#8221; from your broker, bank, trustee or nominee that holds your shares giving you the right to vote the shares at the Meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">The Proxy Statement describing the various matters to be voted upon at the Meeting and the accompanying proxy card will be mailed to shareholders. Shareholders may also review the full version of the
        proposed resolutions in the Proxy Statement as well as the accompanying proxy card, via the website of the U.S. Securities and Exchange Commission at<u>&#160;</u><u>www.sec.gov</u> as well as under the Investors section of our website at <u>http://ir.check-cap.com</u>,
        and also at our offices during regular business hours (Check-Cap Building, 29 Abba Hushi Avenue, P.O. Box 1271, Isfiya, 3009000, Mount Carmel, Israel; Tel: +972-4-+972-4-8303401 (phone)).&#160; Our company&#8217;s representative is Mira Rosenzweig, our Chief
        Financial Officer, at <u>mira.rosenzweig@check-cap.com</u> or +972-4-8303415 or +972-4-8303401, Check-Cap Ltd., Check-Cap Building, 29 Abba Hushi Avenue, P.O. Box 1271, Isfiya, 3009000, Israel. Detailed voting instructions are provided both in the
        Proxy Statement and the proxy card.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Quorum</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The presence, in person or by proxy, of two or more shareholders holding or representing, in the aggregate, at least twenty-five percent (25%) of our company&#8217;s voting rights will
      constitute a quorum at the Meeting.&#160; No business will be considered or determined at the Meeting unless the requisite quorum is present within half an hour from the time designated for the Meeting.&#160; If within half an hour from the time designated for
      the Meeting a quorum is not present, the Meeting will stand adjourned to the same day in the following week, at the same time and place.&#160; At least two shareholders present, in person or by proxy, will constitute a quorum at the adjourned meeting.&#160;
      This notice will serve as notice of such reconvened meeting if no quorum is present at the original date and time and no further notice of the reconvened meeting will be given to shareholders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Vote Required for Approval of the Proposals</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Each ordinary share entitles the holder to one vote.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting, in person or by proxy, and voting on the matter, is required to approve each of
      the proposals.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">The approval of Proposal 3 is also subject to the fulfillment of one of the following additional voting requirements (the &#8220;Special Majority&#8221;): (i) a majority of the shares held by shareholders who
        are not controlling shareholders and shareholders who do not have a personal interest in the proposal, present in person or by proxy and voting on the matter at the Meeting (excluding abstentions), voted in favor of the proposal, or (ii) the total
        number of shares voted against the proposal by shareholders who are not controlling shareholders and shareholders who do not have a personal interest in the proposal does not exceed two-percent (2%) of our outstanding voting rights.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">We are unaware of any shareholder that would be deemed to be a controlling shareholder of our company as of the current time for purposes of Proposal 3.&#160; <font style="font-weight: bold;">A
          shareholder who signs and returns a proxy card will be deemed to be confirming that such shareholder, and any related party of such shareholder, is not a controlling shareholder for purposes of Proposal </font><font style="font-weight: bold;">3</font><font style="font-weight: bold;">.&#160; If you believe that you, or a related party of yours, may be deemed to be a controlling shareholder and you wish to participate in the vote on Proposal </font><font style="font-weight: bold;">3</font><font style="font-weight: bold;">, you should contact our Chief Financial Officer, Mira Rosenzweig, at </font><font style="font-weight: bold;"><u>mira.rosenzweig@check-cap.com</u></font><font style="font-weight: bold;"> or +972-4-8303415 or
          +972-4-8303401</font>.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold;">The Israeli Companies Law, 1999 (the &#8220;Israeli Companies Law&#8221;) requires that each shareholder voting on Proposal </font><font style="font-weight: bold;">3</font><font style="font-weight: bold;"> indicate on the proxy card, or, if voting in person at the Meeting, inform us prior to voting on the matter at the Meeting, whether or not the shareholder has a personal interest in such proposal.&#160; Otherwise, the
          shareholder is not eligible to vote on the proposal and his or her vote will not be counted for the purposes of the proposal.</font>&#160; Under the Israeli Companies Law, a &#8220;personal interest&#8221; of a shareholder in an act or transaction of a company
        (i) includes a personal interest of (a) any spouse, sibling, parent, grandparent or descendant of the shareholder, any descendant, sibling or parent of a spouse of the shareholder and the spouse of any of the foregoing; and (b) a company with
        respect to which the shareholder (or any of the foregoing relatives of the shareholder) owns at least 5% of the outstanding shares or voting rights, serves as a director or chief executive officer or has the right to appoint one or more directors
        or the chief executive officer; and (ii) excludes a personal interest arising solely from the ownership of shares.&#160; Under the Israeli Companies Law, in the case of a person voting by proxy, &#8220;personal interest&#8221; includes the personal interest of
        either the proxy holder or the shareholder granting the proxy, whether or not the proxy holder has discretion how to vote.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="line-height: 1.25">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50%;">
              <div>
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Sincerely,</div>
                <div style="line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">/s/ Steven Hanley</div>
                <div style="line-height: 1.25;">&#160;</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Steven Hanley<br>
                  <font style="font-style: italic;">Chairman of the Board of Directors</font></div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <br>
    <div style="text-align: justify; line-height: 1.25;">October 21, 2021</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">ii</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Check-Cap Ltd.</div>
    <div style="text-align: center; line-height: 1.25;">Check-Cap Building</div>
    <div style="text-align: center; line-height: 1.25;">29 Abba Hushi Avenue</div>
    <div style="text-align: center; line-height: 1.25;">P.O. Box 1271</div>
    <div style="text-align: center; line-height: 1.25;">Isfiya, 3009000</div>
    <div style="text-align: center; line-height: 1.25;">Israel</div>
    <div style="text-align: center; line-height: 1.25;">_____________________</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">PROXY STATEMENT</div>
    <div style="line-height: 1.25; font-size: 12pt;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">2021 ANNUAL GENERAL MEETING OF SHAREHOLDERS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This Proxy Statement is being furnished in connection with the solicitation of proxies on behalf of the Board of Directors of Check-Cap Ltd. (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; or the &#8220;Company&#8221;)
      to be voted at the 2021 Annual General Meeting of Shareholders (the &#8220;Meeting&#8221;), and at any adjournment thereof, pursuant to the accompanying Notice of 2021 Annual General Meeting of Shareholders.&#160; The Meeting will be held on Thursday, December 2,
      2021, at 4:00 p.m. (Israel time) at our offices at the Check-Cap Building, 29 Abba Hushi Avenue, P.O. Box 1271, Isfiya, 3009000, Israel.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Purpose of the Annual General Meeting</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">At the Meeting, shareholders will be asked to consider and vote upon the following: (i) the re-election of all five directors to serve as members of our Board of Directors, until our next annual
        general meeting of shareholders and until their respective successors are duly elected; (ii) the approval of the remuneration to be paid to each of the director nominees, subject to their re-election at the Meeting; (iii) the approval of amended
        annual bonus terms for Mr. Alex Ovadia, our Chief Executive Officer, and a one-time award of options to Mr. Ovadia; and (iv) the ratification and approval of the reappointment of Brightman Almagor Zohar &amp; Co., Certified Public Accountants, a
        firm in the Deloitte Global Network, as our independent auditor for the year ending December 31, 2021 and for such additional period until our next annual general meeting.&#160; In addition, at the Meeting, representatives of our management will be
        available to review and discuss our financial statements for the year ended December 31, 2020.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are not aware of any other matters that will come before the Meeting.&#160; If any other matters properly come before the Meeting, the persons designated as proxies intend to vote on
      such matters in accordance with the judgment and recommendation of the Board of Directors.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Recommendation of the Board of Directors</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our Board of Directors recommends a vote FOR each of the proposals set forth in this Proxy Statement.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Who Can Vote</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You are entitled to notice of, and to vote in person or by proxy at, the Meeting, if you are a holder of record of our ordinary shares as of the close of business on October 26,
      2021.&#160; You are also entitled to notice of the Meeting and to vote at the Meeting if you held ordinary shares through a bank, broker or other nominee that is one of our shareholders of record at the close of business on October 26, 2021, or which
      appeared in the participant listing of a securities depository on that date.&#160; See below &#8220;How You Can Vote.&#8221;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">How You Can Vote</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><font style="font-weight: bold; font-style: italic;">Voting in Person</font>.&#160; If you are a shareholder of record, i.e., your shares are registered directly in your name with our transfer agent, American Stock Transfer &amp; Trust Company
              LLC, you may attend and vote in person at the Meeting.&#160; If you are a beneficial owner of shares registered in the name of your broker, bank, trustee or nominee (i.e., your shares are held in &#8220;street name&#8221;), you are also invited to attend the
              Meeting; however, to vote in person at the Meeting as a beneficial owner, you must first obtain a &#8220;legal proxy&#8221; from your broker, bank, trustee or nominee that holds your shares giving you the right to vote the shares at the Meeting.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><font style="font-weight: bold; font-style: italic;">Voting by Proxy</font>.&#160; If you are a shareholder of record, these proxy materials are being sent directly to you by our transfer agent. You may submit your proxy by completing, signing
              and mailing the enclosed proxy card that was mailed to you in the enclosed, postage-paid envelope.&#160; If your ordinary shares are held in &#8220;street name,&#8221; these proxy materials are being forwarded to you by the broker, trustee or nominee or an
              agent hired by the broker, trustee or nominee.&#160; Please follow the voting instructions provided to you by your broker, trustee or nominee.&#160; Proxies must be received by our transfer agent or at our registered office in Israel no later than
              forty-eight (48) hours prior to the designated time for the Meeting. Proxies received by our transfer agent or at our registered office in Israel during the forty-eight (48) hours preceding the designated time for the Meeting will be
              presented to the Chairman of the Meeting and, at his discretion, may be voted as specified in the instructions included in such proxies.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Change or Revocation of Proxy</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If you are a shareholder of record, you may change your vote at any time prior to the exercise of authority granted in the proxy by delivering a written notice of revocation to our
      Chief Financial Officer, by granting a new proxy bearing a later date, or by attending the Meeting and voting in person.&#160; Attendance at the Meeting will not cause your previously granted proxy to be revoked unless you specifically so request.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If your shares are held in &#8220;street name,&#8221; you may change your vote by submitting new voting instructions to your broker, bank, trustee or nominee or, if you have obtained a legal
      proxy from your broker, bank, trustee or nominee giving you the right to vote your shares, by attending the Meeting and voting in person.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Quorum</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The presence, in person or by proxy, of two or more shareholders holding or representing, in the aggregate, at least twenty-five percent (25%) of our company&#8217;s voting rights will
      constitute a quorum at the Meeting.&#160; No business will be considered or determined at the Meeting unless the requisite quorum is present within half an hour from the time designated for the Meeting.&#160; If within half an hour from the time designated for
      the Meeting a quorum is not present, the Meeting will stand adjourned to the same day in the following week, at the same time and place.&#160; At least two shareholders present, in person or by proxy, will constitute a quorum at the adjourned meeting.&#160;
      This notice will serve as notice of such reconvened meeting if no quorum is present at the original date and time and no further notice of the reconvened meeting will be given to shareholders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Abstentions and broker non-votes will be counted towards the quorum.&#160; Broker non-votes occur when brokers that hold their customers&#8217; shares in street name sign and submit proxies
      for such shares and vote such shares on some matters but not on others.&#160; This occurs when brokers have not received any instructions from their customers, in which case the brokers, as the holders of record, are permitted to vote on &#8220;routine&#8221;
      matters, but not on non-routine matters.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Unsigned or unreturned proxies, including those not returned by banks, brokers, or other record holders, will not be counted for quorum or voting purposes.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Vote Required for Approval of the Proposals</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Each ordinary share entitles the holder to one vote.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting, in person or by proxy, voting on the matter, is required to approve each of the
      Proposals being presented at the Meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">The approval of Proposal 3 is also subject to the fulfillment of one of the following additional voting requirements (the &#8220;Special Majority&#8221;): (i) a majority of the shares held by shareholders who
        are not controlling shareholders and shareholders who do not have a personal interest in the proposal, present in person or by proxy and voting on the matter at the Meeting (excluding abstentions), voted in favor of the proposal, or (ii) the total
        number of shares voted against the proposal by shareholders who are not controlling shareholders and shareholders who do not have a personal interest in the proposal does not exceed two-percent (2%) of our outstanding voting rights.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;">We are unaware of any shareholder that would be deemed to be a controlling shareholder of our company as of the current time for purposes of Proposal 3.&#160; <font style="font-weight: bold;">A shareholder who signs and returns a proxy card will be deemed to be confirming that such shareholder, and any related party of such shareholder, is not a controlling shareholder for purposes of Proposal </font><font style="font-weight: bold;">3</font><font style="font-weight: bold;">.&#160; If you believe that you, or a related party of yours, may be deemed to be a controlling shareholder and you wish to participate in the vote on Proposal </font><font style="font-weight: bold;">3</font><font style="font-weight: bold;">, you should contact our Chief Financial Officer, Mira Rosenzweig, at </font><font style="font-weight: bold;"><u>mira.rosenzweig@check-cap.com</u></font><font style="font-weight: bold;"> or +972-4-8303415 or +972-4-8303401</font>.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25; text-align: justify;"><font style="font-weight: bold;">The Israeli Companies Law, 1999 (the &#8220;Israeli Companies Law&#8221;) requires that each shareholder voting on Proposal </font><font style="font-weight: bold;">3</font><font style="font-weight: bold;"> indicate on the proxy card, or, if voting in person at the Meeting, inform us prior to voting on the matter at the Meeting, whether or not the shareholder has a personal interest in such proposal.&#160;
          Otherwise, the shareholder is not eligible to vote on the proposal and his or her vote will not be counted for the purposes of the proposal.</font>&#160; Under the Israeli Companies Law, a &#8220;personal interest&#8221; of a shareholder in an act or transaction
        of a company (i) includes a personal interest of (a) any spouse, sibling, parent, grandparent or descendant of the shareholder, any descendant, sibling or parent of a spouse of the shareholder and the spouse of any of the foregoing; and (b) a
        company with respect to which the shareholder (or any of the foregoing relatives of the shareholder) owns at least 5% of the outstanding shares or voting rights, serves as a director or chief executive officer or has the right to appoint one or
        more directors or the chief executive officer; and (ii) excludes a personal interest arising solely from the ownership of shares.&#160; Under the Israeli Companies Law, in the case of a person voting by proxy, &#8220;personal interest&#8221; includes the personal
        interest of either the proxy holder or the shareholder granting the proxy, whether or not the proxy holder has discretion how to vote.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In tabulating the voting results for any particular proposal, shares that constitute broker non-votes and abstentions are not considered votes cast on that proposal, and will have
      no effect on the vote.&#160; Unsigned or unreturned proxies, including those not returned by banks, brokers, or other record holders, will not be counted for voting purposes. Therefore, it is important for a shareholder that holds ordinary shares through
      a bank or broker to instruct its bank or broker how to vote its shares if the shareholder wants its shares to count towards the vote tally for a given proposal.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Position Statements</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with the Israeli Companies Law, 1999 (the &#8220;Israeli Companies Law&#8221;) and regulations promulgated thereunder, any shareholder may submit to us a position statement on
      its behalf, expressing its position on an agenda item for the Meeting to our offices, Check-Cap Building, 29 Abba Hushi Avenue, P.O. Box 1271, Isfiya, 3009000, Israel, Attention: Mira Rosenzweig, Chief Financial Officer, or by facsimile to
      +972-4-8211267, no later than November 22, 2021 at 4:00 pm Israel time.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Cost of Soliciting Votes for the Meeting</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We will bear the cost of soliciting proxies from our shareholders.&#160; Proxies will be solicited by mail and may also be solicited in person, by telephone or electronic communication,
      by our directors, officers and employees.&#160; We will reimburse brokerage houses and other custodians, nominees and fiduciaries for their expenses in accordance with the regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) concerning
      the sending of proxies and proxy material to the beneficial owners of our shares.&#160; In addition, we have retained Kingsdale Advisors to assist in the solicitation of proxies for a fee of US$10,000 plus telephone solicitation fees and reimbursement of
      expenses.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If you have questions about this Proxy Statement or the Meeting, please contact Kingsdale Advisors, our proxy solicitor, by telephone at 1-866-581-0510 (shareholders) and (416)
      867-2272 (banks and brokerage firms), or by email at <font style="font-weight: bold;"><u>contactus@kingsdaleadvisors.com</u></font>.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Security Ownership of Certain Beneficial Owners and Management</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As of October 21, 2021, (i) no person or entity known to us to beneficially owned more than 5% of our outstanding ordinary shares; (ii) no current executive officer or director
      individually beneficially owned 1% or more of our outstanding ordinary shares; and (ii) all of our current executive officers and directors as a group beneficially owned 0.48% of our outstanding shares.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The percentage of beneficial ownership of our ordinary shares is based on 96,404,949 ordinary shares, NIS 2.40 par value per share, outstanding as of October 20, 2021.&#160; Beneficial
      ownership is determined in accordance with the rules of the SEC and generally includes voting power or investment power with respect to securities.&#160; All ordinary shares underlying options and warrants currently exercisable or exercisable into
      ordinary shares within 60 days of October 21, 2021 and underlying restricted stock units (&#8220;RSUs&#8221;) that vest within 60 days of October 21, 2021 are deemed to be outstanding and beneficially owned by the person or entity holding such options or
      warrants for the purpose of computing the number of shares beneficially owned by such person or entity. Such shares are also deemed outstanding for purposes of computing the percentage ownership of the person holding the option, warrant or RSU. They
      are not, however, deemed to be outstanding and beneficially owned for the purpose of computing the percentage ownership of any other person or entity.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Executive Officer Compensation</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">For information regarding the compensation incurred by us in relation to our five most highly compensated office holders (within the meaning of the Israeli Companies Law) for the
      year ended December 31, 2020, see &#8220;Item 6B. Directors, Senior Management and Employees &#8212; Compensation of Directors and Executive Officers&#8221; of our annual report on Form 20-F for the year ended December 31, 2020, filed with the SEC on March 18, 2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL 1</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">RE-ELECTION OF DIRECTORS</div>
    <div style="text-align: center; line-height: 1.25;">(Item 1 on the Proxy Card)</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Composition of the Board of Directors</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under our articles of association, as currently in effect, our Board of Directors must consist of at least four and not more than eleven directors.&#160; Our Board of Directors
      currently consists of five directors, Steven Hanley, Clara Ezed, Dr. Mary Jo Gorman, XiangQian (XQ) Lin and Yuval Yanai.&#160; Each of our directors holds office until the next annual general meeting of shareholders following his or her appointment
      (unless the tenure of such director expires earlier or a director is removed from office pursuant to the Israeli Companies Law).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">All of our currently serving directors are standing for re-election at the Meeting, to hold office until our next annual general meeting of shareholders and until his or her
      successor is elected and qualified.&#160; Our Board of Directors has affirmatively determined that each of Clara Ezed, Dr. Mary Jo Gorman, Yuval Yanai and XiangQian (XQ) Lin<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup>is an &#8220;independent director&#8221; as defined under Nasdaq Listing Rules.&#160;
      Accordingly, subject to shareholder approval of the above director nominees, our Board of Directors will consist of five members, four of whom satisfy the independence requirements of the Nasdaq Listing Rules.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Suitability of Director Nominees</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our Nominating Committee and Board of Directors have reviewed the qualifications and suitability of each of the director nominees.&#160; In accordance with the Israeli Companies Law,
      each of the director nominees has certified to us that he or she meets all the requirements of the Israeli Companies Law for election as a director of a public company, and possesses the necessary qualifications and is able to dedicate sufficient
      time to fulfill his or her duties as a director of our company, taking into consideration our company&#8217;s size and special needs. Accordingly, upon the recommendation of our Nominating Committee, our Board of Directors has nominated the five
      individuals named below for re-election, to hold office until our next annual general meeting of shareholders, subject to our articles of association and applicable law.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">4</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic;">Nominees for Director</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following biographical information is provided with respect to each director nominee based upon our records and information provided to us by each nominee.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">Steven Hanley</font> has served as a member of our Board of Directors since February 2015 and as the Chairman of our Board of
      Directors since September 2017, and has served as a member of our Nominating Committee since October 2015 and as a member of our Financing Committee since June 2016.&#160; Mr. Hanley served as a member of our Audit Committee from March 2015 until December
      2017 and as a member of our Compensation Committee from March 2015 until March 2019. Mr. Hanley is currently the Co-Founder, board member and Chief Executive Officer of MediBeacon Inc., an optical diagnostic company based in St. Louis, Missouri
      formed upon acquiring assets and intellectual property from Covidien in 2012.&#160; Mr. Hanley is an experienced global business leader who has managed highly complex pharmaceutical and medical device operations with annual global revenue exceeding US$1
      billion.&#160; As the President of Covidien plc&#8217;s Imaging Solutions business unit, Mr. Hanley led a multifunctional organization that included sales, marketing, logistics, manufacturing, as well as research and development.&#160; Internationally, Mr. Hanley&#8217;s
      track record includes numerous new drug and device product introductions and sales force expansion in Eastern Europe, China and Latin America. Mr. Hanley is experienced working in different cultures and successfully navigating dynamic regulatory
      environments.&#160; Over his nearly 18 years with the Covidien family of companies, Mr. Hanley developed a large network of business leaders and clinicians to help determine market needs, commercial potential and product positioning.&#160; As a sales leader,
      Mr. Hanley called on radiologists, nuclear medicine physicians, cardiologists, as well as surgeons in specialties including general, orthopedic, and OB/GYN.&#160; Mr. Hanley is Principal and Founder of Neem LLC, which was founded in 2009 to focus on
      startup and entrepreneurial medical device and other life science companies with whom the firm works to bridge the gap between breakthrough technology and commercialization.&#160; Mr. Hanley is the Chairman of the Board of Managers for Daya CNS LLC, based
      in St Louis Missouri.&#160; In addition, Mr. Hanley is currently on the Advisory Board for Kogent Surgical LLC, based in St Louis Missouri.&#160; Mr. Hanley provided consultancy services to us on behalf of Neem LLC from November 2009 until December 31, 2014
      and served as a Scientific Advisor to our company from June 2011 until his election to our Board of Directors in February 2015. Mr. Hanley holds B.A. and M.A. degrees in business administration from Marquette University.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">Clara Ezed</font> has served as a member of our Board of Directors since June 2017, and has served as a member of our Audit
      Committee since December 2017 and as a member of our Compensation Committee since March 2019. Ms. Ezed serves as an Executive Board Director, Business Development of DLRC Ltd., an EU based life-sciences consulting firm, since May 2021.&#160; Ms. Ezed
      served as Head of EU Operations, EU General Counsel and VP European Regulatory Affairs of La Jolla Pharmaceutical, a San Diego based biopharmaceutical company, from December 2017 to December 2020.&#160; Prior to that, Ms. Ezed served as VP, Legal &amp;
      Regulatory Affairs of Emas Pharma Ltd., a global contract research organization, from October 2013 to November 2017. From September 2009 to October 2013, Ms. Ezed served as VP, Regulatory Affairs &amp; Drug Safety of European Medical Advisory
      Services Ltd., a global contract research organization. Since 2011, Ms. Ezed has served as a director of a privately listed company, Sebaroyale Ltd, focused on the development and commercialization of a range of cosmeceuticals. Ms. Ezed, a lawyer and
      pharmacist with 22 years&#8217; experience working in the pharmaceutical industry, has managed a large and varied portfolio working in regulatory and medical affairs, quality assurance, clinical operations and pharmacovigilance. Ms. Ezed holds a BSc. in
      Pharmacy from the University of Strathclyde, an MBA degree from Middlesex University, a Postgraduate Diploma in Pharmacovigilance from the University of Hertfordshire, a Postgraduate Diploma in Law from Nottingham University and a Postgraduate
      Diploma in Legal Professional Services from City Law School, London. Ms. Ezed is a member of the Bar of England and Wales and a member of the General Pharmaceutical Council.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">Dr. Mary Jo Gorman</font> has served as a member of our Board of Directors and as a member of our Audit Committee and
      Compensation Committee since May 2015, and has served as a member of our Financing Committee since June 2016. From 2019 to 2021, Dr. Gorman was the chief executive officer of Healthy Bytes, a venture backed healthcare services company, located in St.
      Louis, Missouri.&#160; Dr. Gorman also serves as Managing Director at Prosper Capital, an early stage investment fund focused on women-led businesses. In 2006, Dr. Gorman founded Advanced ICU Care, the largest telemedicine ICU services provider in the
      United States, in which she also served as Chairman and Chief Executive Officer from 2006 and 2014. From December 2016 to 2018, Dr. Gorman served as interim CEO and as a member of the audit committee of TripleCare, a U.S. provider of
      telemedicine-based healthcare services to skilled nursing facilities, subsequently sold to Curavi Health. Dr. Gorman served on the board of directors of Curavi Health from 2019 to July 2020.&#160; From 1999 to 2006, Dr. Gorman served at IPC-The
      Hospitalist Company (Nasdaq:IPCM), a leading national physician group practice, as Chief Medical Officer (2003-2006), Vice President of Medical Affairs (2001-2003) and Regional Medical Director (1999-2001). From 1996 to 1998, Dr. Gorman served as
      President of Inpatient Care Group, a hospitalist group in St. Louis, Missouri, which she had founded to provide hospitalist services to primary care physicians and hospitals and which was subsequently sold to IPC. From 1991 to 2008, Dr. Gorman served
      as President of Critical Care Services, Inc., a privately held corporation which she had founded and which was later sold to Advanced ICU Care. Dr. Gorman was awarded with the following awards: 2015 Distinguished Alumni Award, Southern Illinois
      University School of Medicine; 2013 Distinguished Alumni Award, Olin School of Business, Washington University; 2011 EY Entrepreneurial Winning WomenTM Class of 2011; 2009 Top 25 Influential Women in Healthcare by Modern HealthCare Magazine. Dr.
      Gorman holds a B.A. degree in Chemistry and Biology (Cum Laude) from St. Louis University, an M.B.A degree from Olin School of Business, Washington University and an M.D. from Southern Illinois University School of Medicine.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">5</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">XiangQian (XQ) Lin</font> has served as a member of our Board of Directors since February 2015. Mr. Lin has served as the
      President and Chief Executive Officer of the Esco Group since 2011, and is a life sciences entrepreneur and investor with a demonstrated track record across the United States, Asia and Europe.&#160; In 2018, Mr. Lin served as the founder and managing
      partner of EVX Ventures, a venture capital firm which builds and invests in biotech companies across Asia. Mr. Lin has co-founded multiple companies including Carmine Therapeutics and PairX Bio.&#160;&#160; Mr. Lin holds a BSc degree in Economics and Finance
      from the Wharton School of Business, University of Pennsylvania.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">Yuval Yanai </font>has served as a member of our Board of Directors since March 2015 and has served as the Chairman of our
      Audit Committee and Compensation Committee since March 2015, as the Chairman of our Nominating Committee since October 2015 and as the Chairman of our Financing Committee since June 2016.&#160; Mr. Yanai served as Senior Vice President and Chief Financial
      Officer of Given Imaging Ltd. from September 2005 through March 2014.&#160; From October 2000 through August 2005, Mr. Yanai served as Senior Vice President and Chief Financial Officer of Koor Industries Ltd.&#160; Prior to that, from April 1998 to September
      2000, Mr. Yanai served as Vice President and Chief Financial Officer of NICE Systems Ltd., an Israeli global provider of Insight from Interactions, and, from 1991 to April 1998, he served as the Vice President, Finance and Chief Financial Officer of
      Elscint Ltd., a former Israeli company engaged in the developing and manufacturing of medical imaging devices.&#160; Mr. Yanai joined Elscint in 1985 and served as Corporate Controller and Corporate Treasurer through 1991. Mr. Yanai also serves as an
      external director (within the meaning of the Israeli Companies Law) of S&amp;P Global Maalot. Mr. Yanai also serves as an external director (within the meaning of the Israeli Companies Law) of Clal Biotechnology Industries and serves as the Chairman
      of its audit, financial reporting and compensation committees. Mr. Yanai also serves as a member of the board of directors of PulseNmore Ltd. and as a member of its finance and audit committees.&#160; Mr. Yanai also serves as a member of the board of
      directors of Nobio Ltd. and BRH Medical Ltd and as an acting CFO (part time) of Art Medical Ltd. Mr. Yanai also serves as the Chairman of The Israeli Fund for UNICEF (pro bono).&#160; Previously, Mr. Yanai served as an external director (within the
      meaning of the Israeli Companies Law) of Hadassah Medical Organization and as the Chairman of its finance and compensation committees and as a member of its tenders and donation committee.&#160; Mr. Yanai also previously served as an external director
      (within the meaning of the Israeli Companies Law) of Mazor Robotics Ltd. and Medical Compression Systems Ltd. and as a director of Medigus Ltd. and Alcobra Ltd. Mr. Yanai also served as a director of Macrocure Ltd., Citycon Oj, Starplast Industries
      Ltd., Adama Ltd. (formerly Makteshim-Agan Industries Ltd.), ECI Telecom Ltd., Equity One, Inc., BVR Systems Ltd., Tadiran Communication Ltd., The Elisra Group, Telrad Networks Ltd. and Medical Compression Systems (D.B.N) Ltd.&#160; Mr. Yanai holds a B.Sc.
      degree in Accounting and Economics from Tel-Aviv University.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are not aware of any reason why the nominees, if elected, would be unable or unwilling to serve as directors.&#160; Should the nominees be unavailable for election, the proxies will
      be voted for substitute nominees designated by our Board of Directors.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If re-elected at the Meeting, the director nominees shall be entitled to the compensation and benefits set forth in Proposal 2, subject to shareholder approval at the Meeting.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law, the affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting, in person or by proxy, and voting on the matter, is required to
        elect as directors the nominees named above.&#160; Each director nominee shall be voted on separately.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25; font-weight: bold;">The Board of Directors recommends a vote FOR the re-election of each nominee for director named above.</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">6</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL 2</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">APPROVAL OF REMUNERATION FOR DIRECTORS</font><br>
      (Item 2 on the Proxy Card)</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law, the terms of remuneration payable to a director of a public company require the approval of the compensation committee, board of directors and the
      shareholders, in that order.&#160; Subject to the re-election of the director nominees listed in Proposal 1, our Compensation Committee and Board of Directors have approved, subject to shareholder approval, the payment to each such director the following
      fees, all to be paid on a quarterly basis:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><u>Annual fees</u>: An annual fee of (i) US$25,000 for service on the Board of Directors; and (ii) US$2,500 for service on the Audit Committee.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><u>Per meeting fee</u>: A per meeting fee of US$850 for each meeting of the Board of Directors or any committee thereof attended in person or via telephone or any resolution approved by written consent.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><u>Chairman fee</u>: An annual fee of (i) US$10,000 for service as Chairman of the Board of Directors (other than an Active Chairman, who may be entitled to an increased fee in accordance with our Compensation Policy); and (ii) US$5,000
              for service as Chairman of the Audit Committee.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The foregoing fees are the same annual and per meeting fees that have been paid to our directors since our 2017 annual general meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, if re-elected at the Meeting, our directors will continue to benefit from the directors&#8217; and officers&#8217; indemnification and exculpation agreement that we previously
      entered into with each of them, as well as from our directors&#8217; and officers&#8217; liability insurance policy, as in effect from time to time.&#160; The directors, if re-elected, will also be entitled to reimbursement of expenses (including travel, stay and
      lodging), subject to the Israeli Companies Law and the regulations promulgated thereunder, and in accordance with our company practices and our Compensation Policy, as in effect from time to time.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The proposed payment of annual and per meeting fees to our directors and other compensation terms are consistent with our Compensation Policy for Executive Officers and Directors,
      as approved by our shareholders at our 2020 annual general meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">To our knowledge, there are no agreements or arrangements between any director or director nominee and any third party relating to compensation or other payment in connection with
      their candidacy or service on our Board of Directors.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">It is therefore proposed that at the Meeting the following resolution be adopted:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;RESOLVED, that the remuneration to be paid to each director of the Company, subject to their re-election at the Meeting, as set forth in Proposal 2 of the Proxy Statement for
      the Meeting be, and hereby is, approved.&#8221;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law, the affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting, in person or by proxy, and voting on the
      matter, is required to approve the foregoing resolution.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold;">The Board of Directors recommends a vote FOR the foregoing resolution.&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">7</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL 3</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">APPROVAL OF AMENDED BONUS TERMS AND AWARD OF EQUITY-BASED </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">COMPENSATION TO OUR CHIEF EXECUTIVE OFFICER</div>
    <div style="text-align: center; line-height: 1.25;">
      <div style="line-height: 1.25;">(Items 3A and 3B on the Proxy Card)</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">Mr. </font>Alex Ovadia has served as our Chief Executive Officer since February 26, 2018.&#160; Prior to that, Mr. Ovadia
      served as our Chief Operating Officer and Israeli Site Manager from July 1, 2015, in addition to serving as our Vice President of Research and Development from January 2013. Mr. Ovadia has also served as a member of the Board of Directors of our U.S.
      subsidiary, Check-Cap US, Inc., since March 2018.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">At the extraordinary general meeting of shareholders held on April 2, 2018, our shareholders approved the initial terms of engagement of Mr. Ovadia as our Chief Executive Officer, which were
        substantially the same economic terms to which he was entitled when he served in his former position as our Chief Operating Officer, Vice President of Research and Development and Israeli Site Manager.&#160; Since Mr. Ovadia&#8217;s appointment as Chief
        Executive Officer in February 2018, his compensation terms have not been amended (other than an approximately total 9.7% salary increase) and no equity-based awards have been awarded to Mr. Ovadia since our 2019 annual general meeting of
        shareholders.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">Our Compensation Committee and Board of Directors conducted a review and discussion regarding Mr. Ovadia&#8217;s compensation terms, including salary, benefits, bonus and equity awards, and in connection
        with such review, reviewed peer group analysis of compensation of other chief executive officers of Israeli public companies in industries similar to ours.&#160; Based on their review, the Compensation Committee and Board of Directors determined that
        Mr. Ovadia&#8217;s overall compensation is low as compared to his peers and that it is in the best interest of the Company to keep competitive with peer companies in order to retain Mr. Ovadia, in a competitive market for talent, particularly as the
        Company heads towards the initiation of the U.S. pivotal study and significant milestones.&#160; The Compensation Committee and Board of Directors noted Mr. Ovadia&#8217;s strong leadership and his significant contribution to our ongoing operations during his
        tenure, including his management of the COVID-19 pandemic crisis, the recent capital raises during the period of the pandemic, his ongoing efforts to the clinical development plan and manufacturing efforts and his management of employee retention,
        resulting in low employee turnover rates.</div>
      <div style="text-indent: 36pt; line-height: 1.25;"> <br>
        <div style="text-indent: 36pt; line-height: 1.25;">In view of the foregoing considerations, the Compensation Committee and Board of Directors approved, subject to shareholder approval, the following:</div>
        <div style="text-indent: 36pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-indent: 36pt; line-height: 1.25; margin-left: 36pt;">
          <table cellspacing="0" cellpadding="0" border="0" align="left" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

              <tr>
                <td style="width: 2%; text-align: left; vertical-align: top;">
                  <div>&#8226;</div>
                </td>
                <td style="width: 98%;">
                  <div>
                    <div style="text-align: justify; line-height: 1.25;">An increase to Mr. Ovadia&#8217;s annual bonus such that Mr. Ovadia would be entitled to an annual bonus of up to 50% of his annual base salary (instead of 30% of the annual base salary),
                      effective as of the 2022 annual bonus.&#160; Of the annual bonus, (i) 80% is subject to the achievement of measurable criteria determined by our Compensation Committee and Board of Directors, in accordance with our Compensation Policy, as
                      in effect and approved by our shareholders from time to time, and (ii) 20% of the annual bonus is based on non-measurable criteria.</div>
                    <div style="text-align: justify; line-height: 1.25;"> <br>
                    </div>
                    <div style="text-align: justify; line-height: 1.25;">
                      <div>
                        <div style="line-height: 1.25;">
                          <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Board of Directors and Compensation Committee may determine that Mr. Ovadia shall be entitled to certain portion(s) of the bonus upon partial
                            achievement of the criteria and that the bonus shall be conditioned upon the achievement of a minimum threshold of the criteria.&#160; The Board of Directors and Compensation Committee may further determine that in the event that Mr.
                            Ovadia&#8217;s employment terminates prior to the end of a full 12-month period, he shall be entitled to the relative portion of the bonus, based on the actual employment term during the 12-month period.&#160; In the event of termination
                            for &#8220;Cause&#8221; (as such term is defined in Mr. Ovadia&#8217;s employment agreement), he shall not be entitled to any bonus for the 12-month period during which his employment was terminated.&#160; Mr. Ovadia shall be required to repay any
                            amounts paid to him as a bonus, if subsequently it transpires that such amounts were paid on the basis of figures that were incorrect and were restated in the Company financial statements, all in accordance with applicable law
                            and our Compensation Policy.</div>
                        </div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
        <div style="text-indent: 36pt; line-height: 1.25; clear: both;">&#160;<br>
          <div style="text-indent: 36pt; line-height: 1.25; margin-left: 36pt;">&#160;</div>
          <div>&#160;</div>
        </div>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">8</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div>
        <div>
          <div style="text-indent: 36pt; line-height: 1.25;"> <br>
          </div>
          <div style="text-indent: 36pt; line-height: 1.25; margin-left: 36pt;">
            <table cellspacing="0" cellpadding="0" border="0" align="left" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">

                <tr>
                  <td style="width: 2%; text-align: left; vertical-align: top;">
                    <div>&#8226;</div>
                  </td>
                  <td style="width: 98%;">
                    <div>
                      <div style="text-align: justify; line-height: 1.25;">
                        <div style="line-height: 1.25;">The award to Mr. Ovadia of equity-based compensation, in the form of options, to move his equity ownership near the competitive percentile for the Company&#8217;s peers and to create incentives that will
                          link his compensation to our achievements and the interests of our shareholders, while ensuring that the adequate incentives are put in place to maximize our company&#8217;s long-term value.</div>
                        <div style="line-height: 1.25;"> <br>
                        </div>
                        <div style="line-height: 1.25;">
                          <div>
                            <div style="line-height: 1.25;">
                              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                                <div style="line-height: 1.25;">As of the date hereof, Mr. Ovadia beneficially owns (as determined in accordance with SEC rules, as described above under &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221;), in
                                  the aggregate, approximately 0.09% of our outstanding shares (or 0.15% of our outstanding shares assuming all of the options and RSUs currently held by Mr. Ovadia are fully vested), which is significantly below his peers
                                  who serve as chief executive officers of Israeli public companies in similar industries, as demonstrated by the peer group analysis. To date, we have granted to Mr. Ovadia options to purchase an aggregate 105,774 ordinary
                                  shares and an aggregate 41,519 RSUs.&#160; The large majority of the options have an exercise price that exceeds the current market value of the underlying shares and the majority of the RSUs are performance based.&#160; The
                                  Compensation Committee and Board also considered the current market price of the Company&#8217;s shares.</div>
                                <div style="line-height: 1.25;"> <br>
                                </div>
                                <div style="line-height: 1.25;">
                                  <div>
                                    <div>
                                      <div>
                                        <div>
                                          <div>
                                            <div>Accordingly, our Compensation Committee and Board of Directors approved, subject to shareholder approval, the award to Mr. Ovadia of options to purchase 1,150,000 ordinary shares, which shall vest as
                                              follows: (i) two-thirds of the options shall vest over a period of four years commencing on their date of grant, such that 25% of the options shall vest on the first anniversary of the date of grant and an
                                              additional 2.0833% will vest at the end of each month thereafter; and (ii) one third of the options shall fully vest upon the approval by the FDA of the use of our colorectal cancer screening capsule, C-Scan&#174;,
                                              in humans, subject, in each case, to Mr. Ovadia&#8217; continuing service with the company on each applicable vesting date. The exercise price of the options shall be equal to the higher of (i) the average closing
                                              price of our ordinary shares on the Nasdaq Capital Market during the 30 trading days prior to the approval of the grant of the award by the shareholders at the Meeting and (ii) the closing price of our ordinary
                                              shares on the Nasdaq Capital Market on the date of the approval of the option grant by our shareholders, in each case plus a 50% premium. The options shall be awarded under, and shall be subject to the terms
                                              and conditions of, the 2015 Plan and the award agreement to be entered into with Mr. Ovadia. The estimated fair market value of the proposed options to be granted to Mr. Ovadia, estimated using the closing
                                              price of our ordinary shares on the Nasdaq Capital Market on October 20, 2021 and calculated using the Black &amp; Scholes valuation method, is approximately $900,000. If the shareholders approve the proposed
                                              options award to Mr. Ovadia at the Meeting, assuming all options and RSUs held by Mr. Ovadia immediately following the Meeting are fully vested, Mr. Ovadia would beneficially own 1.33% of our outstanding
                                              ordinary shares as of immediately following the Meeting. The proposed equity-based award to Mr. Ovadia, as described above, is consistent with our Compensation Policy.</div>
                                          </div>
                                        </div>
                                      </div>
                                    </div>
                                  </div>
                                </div>
                              </div>
                            </div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div style="clear: both;"> <br>
        </div>
        <div style="clear: both;">&#160;</div>
      </div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law, the terms of engagement of a chief executive officer, including the award of equity-based compensation to a chief executive officer, that are
      consistent with a company&#8217;s compensation policy, require the approval of the compensation committee, board of directors and shareholders by the Special Majority (in that order).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">It is therefore proposed that at the Meeting the following resolutions be adopted:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; margin-right: 53.85pt; margin-left: 36pt; line-height: 1.25;"><font style="font-weight: bold;">3A: &#8220;</font>RESOLVED, that the amended annual bonus terms for Mr. Alex Ovadia, as set forth in Proposal 3 of the Proxy
        Statement for the Meeting, be, and hereby are, approved.&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-right: 53.85pt; margin-left: 36pt; line-height: 1.25;"><font style="font-weight: bold;">3B: &#8220;</font>RESOLVED, that the award to Mr. Alex Ovadia of options to purchase ordinary shares, in such amount and with
        such terms and conditions (including vesting terms and exercise price), as set forth in Proposal 3 of the Proxy Statement for the Meeting, be, and hereby is, approved.&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law, the affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting, in person or by proxy, and voting on the matter, is required to
        approve the foregoing resolutions.&#160; In addition, the approval of each of Proposal 3A and 3B is also subject to the fulfillment of the Special Majority.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
      <div style="text-indent: 36pt; line-height: 1.25;">The Israeli Companies Law requires that each shareholder voting on Proposal 3A and 3B indicate on the proxy card, or, if voting in person at the Meeting, inform us prior to voting on the matter at
        the Meeting, whether or not the shareholder has a personal interest in such proposal.&#160; Otherwise, the shareholder is not eligible to vote on the proposals and his or her vote will not be counted for the purposes of the proposals.&#160; For details
        regarding the meaning of &#8220;personal interest,&#8221; see above &#8220;Vote Required for Approval of the Proposals.&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold;">The Board of Directors recommends a vote FOR the foregoing resolutions.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">9</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL 4<br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">RATIFICATION AND APPROVAL OF APPOINTMENT OF INDEPENDENT REGISTERED </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PUBLIC ACCOUNTANTS</div>
    <div style="text-align: center; line-height: 1.25;">(Item 4 on the Proxy Card)</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">At the Meeting, shareholders will be asked to ratify and approve the re-appointment of Brightman Almagor Zohar &amp; Co., Certified Public Accountants, a firm in the Deloitte
      Global Network, as our independent registered public accountants for the fiscal year ending December 31, 2021 and for such additional period until our next annual general meeting, pursuant to the recommendation of our Audit Committee and Board of
      Directors.&#160; Brightman Almagor Zohar &amp; Co. has no relationship with us or our U.S. subsidiary except as independent registered public accountants and, from time to time and to a limited extent, as tax consultants and providers of some
      audit-related and other services.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with the rules of the SEC, Israeli law and our Articles of Association, our Audit Committee pre-approves and recommends to the Board, and our Board of Directors
      approves the compensation of Brightman Almagor Zohar &amp; Co. for audit and other services, in accordance with the volume and nature of their services.&#160; Pursuant to the pre-approval and recommendation of our Audit Committee, our Board of Directors
      has approved the engagement of Brightman Almagor Zohar &amp; Co for the audit of our financial statements for the year ending December 31, 2021, for a total remuneration of US$110,000 (plus expenses). From time to time we engage Brightman Almagor
      Zohar &amp; Co. to provide audit related, tax and other services, subject to the pre-approval of our Audit Committee and approval of our Board of Directors.&#160; For the year ended December 31, 2020, we paid Brightman Almagor Zohar &amp; Co US$60,000 for
      audit services, US$15,000 for audit-related services, US$19,437 for tax services and US$7,000 for other services.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">It is therefore proposed that at the Meeting the following resolution be adopted:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; margin-right: 53.85pt; margin-left: 36pt; line-height: 1.25;">&#8220;RESOLVED, that the appointment of Brightman Almagor Zohar &amp; Co., Certified Public Accountants, a firm in the Deloitte Global Network, as the
        independent registered public accountants of the Company for the year ending December 31, 2021 and for such additional period until the next annual general meeting, be and hereby is ratified and approved.&#8221;</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the Israeli Companies Law, the affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting, in person or by proxy, and voting on the
      matter, is required to approve the foregoing resolution.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-weight: bold;">The Board of Directors recommends a vote FOR the foregoing resolution.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">10</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">REVIEW AND DISCUSSION OF FINANCIAL STATEMENTS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our Board of Directors has approved, and is presenting to the shareholders for review and discussion at the Meeting, our audited financial statements for the year ended December
      31, 2020.&#160; This Item will not involve a shareholder vote.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our audited financial statements for the year ended December 31, 2020, which form part of our annual report on Form 20-F for the year ended December 31, 2020 filed with the SEC on
      March 18, 2021, are available for viewing via the SEC&#8217;s website at <u>www.sec.gov</u> as well as under the Investors section of our website at <u>http://ir.check-cap.com/</u>.&#160; Shareholders may receive a hard copy of the annual report on Form 20-F
      containing the audited financial statements free of charge upon request.&#160; None of the audited financial statements, the Form 20-F nor the contents of our website form part of the proxy solicitation material.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We are subject to the information reporting requirements of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), as applicable to foreign private issuers.&#160; We
      fulfill these requirements by filing reports with the SEC.&#160; Our SEC filings are available to the public on the SEC&#8217;s website at <u>www.sec.gov</u>.&#160; As a foreign private issuer, we are exempt from the rules under the Exchange Act related to the
      furnishing and content of proxy statements.&#160; The circulation of this Proxy Statement should not be taken as an admission that we are subject to those proxy rules.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SHAREHOLDER PROPOSALS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Any shareholder who intends to present a proposal at the Meeting must satisfy the requirements of the Israeli Companies Law and the regulations promulgated thereunder.&#160; Under
      Section 66(b) of the Israeli Companies Law, only shareholders who severally or jointly hold at least 1% of or outstanding voting rights are entitled to request that our Board of Directors include a proposal at a future shareholder meeting, provided
      that such proposal is appropriate for consideration by shareholders at such meeting, by submitting such proposal within seven days of publication of a company&#8217;s notice with respect to its general meeting of shareholders.&#160; Accordingly, any such
      shareholders may request to include a proposal on the agenda of the Meeting by submitting their proposals in writing to Mira Rosenzweig, our Chief Financial Officer, at the following address: Check-Cap Ltd., Check-Cap Building, 29 Abba Hushi Avenue,
      P.O. Box 1271, Isfiya, 3009000, Israel, Attention: Chief Financial Officer.&#160; For a shareholder proposal to be considered for inclusion at the Meeting, our Chief Financial Officer must receive the written proposal, together with the accompanying
      documentation and information required to be submitted under Israeli law, no later than October 27, 2021.&#160; If our Board of Directors determines that a shareholder proposal is duly and timely received and is appropriate under applicable Israeli law
      for inclusion on the agenda on the Meeting, we will publish a revised agenda for the Meeting no later than November 3, 2021, by way of issuing a press release or submitting a Report on Form 6-K to the SEC.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">11</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">OTHER MATTERS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our Board of Directors does not intend to bring any matters before the Meeting other than those specifically set forth in the Notice of 2021 Annual General Meeting of Shareholders
      and knows of no matters to be brought before the Meeting by others.&#160; If any other matters properly come before the Meeting, it is the intention of the persons named in the accompanying proxy to vote such proxy in accordance with the judgment and
      recommendation of the Board of Directors.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50%;">
              <div>
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">By Order of the Board of Directors,</div>
                <div style="line-height: 1.25;">&#160;</div>
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">/s/ Steven Hanley</div>
                <div style="line-height: 1.25;">&#160;</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Steven Hanley<br>
                  <font style="font-style: italic;">Chairman of the Board of Directors</font></div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Date: October 21, 2021</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" id="DSPFPageNumber">12</font>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exhibit_99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.6.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">

  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div> <br>
    </div>
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 99.2</font></u><br>
    </div>
    <div>
      <div style="text-align: center; line-height: 1.25;"><img width="123" height="50" src="image0.jpg"></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">CHECK-CAP LTD.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The undersigned hereby appoint(s) Alex Ovadia and Mira Rosenzweig, or either of them, attorneys or attorney of the undersigned, for and in the name(s) of the undersigned, with
        power of substitution and revocation in each to vote any and all ordinary shares, par value NIS 2.40 per share, of Check-Cap Ltd. (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), which the undersigned would be entitled to vote as fully as
        the undersigned could if personally present at the 2021 Annual General Meeting of Shareholders of the Company to be held on Thursday, December 2, 2021, at 4:00 p.m. (Israel time) at the offices of the Company, the Check-Cap Building, 29 Abba Hushi
        Avenue, P.O. Box 1271, Isfiya, 3009000, Israel, and at any adjournment or adjournments thereof, and hereby revoking any prior proxies to vote said shares, upon the following items of business more fully described in the Notice and Proxy Statement
        for the 2021 Annual General Meeting of Shareholders (receipt of which is hereby acknowledged):</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">THIS PROXY WILL BE VOTED AS SPECIFIED ON THE REVERSE.&#160; IN THE ABSENCE OF SUCH SPECIFICATION, THE SHARES REPRESENTED BY THIS PROXY CARD WILL BE VOTED FOR THE ELECTION OF THE
        DIRECTORS NAMED IN ITEM 1 AND FOR EACH OF THE OTHER ITEMS SET FORTH ON THE REVERSE.&#160; ON ANY OTHER BUSINESS THAT MAY PROPERLY COME BEFORE THE MEETING, THIS PROXY WILL BE VOTED IN ACCORDANCE WITH THE JUDGMENT OF THE PERSONS NAMED ABOVE AS PROXIES.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25; font-weight: bold;">VOTES CAST ON ITEMS 3A AND 3B SET FORTH ON THE REVERSE WILL NOT BE COUNTED UNLESS &#8220;YES&#8221; OR &#8220;NO&#8221; HAS BEEN SPECIFIED AS TO WHETHER THE SHAREHOLDER HAS A PERSONAL INTEREST (AS
        DEFINED IN THE PROXY STATEMENT) WITH RESPECT TO SUCH PROPOSAL.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">(Continued and to be signed on the reverse side)</div>
      <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div id="DSPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <br>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">2021 ANNUAL GENERAL MEETING OF SHAREHOLDERS OF</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">CHECK-CAP LTD.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">DECEMBER 2, 2021</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">GO GREEN</div>
      <div style="margin-left: 207pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 100%; vertical-align: bottom; text-align: center;">
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: left;">e-Consent makes it easy to go paperless. With e-Consent, you can quickly access your proxy</div>
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: left;">material, statements and other eligible documents online, while reducing costs, clutter and</div>
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; text-align: left;">paper waste. Enroll today via www.amstock.com to enjoy online access.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Please sign, date and mail</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">your proxy card in the</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">envelope provided as soon</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">as possible.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">&#8595;</font> Please detach along perforated line and mail in the envelope provided. <font style="font-weight: bold;">&#8595;</font></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#8220;FOR&#8221; THE ELECTION OF THE DIRECTORS NAMED IN ITEM 1 AND EACH OF THE OTHER ITEMS SET FORTH BELOW.&#160; PLEASE SIGN, DATE AND RETURN PROMPTLY IN
        THE ENCLOSED ENVELOPE.&#160; PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE &#9746;</div>
      <div style="text-align: justify; line-height: 1.25;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>To re-elect all five directors to serve as members of the Board of Directors of the Company, until the next annual general meeting of shareholders and until their respective successors are duly elected.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 36pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 42.21%; vertical-align: top;">&#160;</td>
              <td style="width: 19.35%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">FOR</div>
              </td>
              <td style="width: 19.22%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">AGAINST</div>
              </td>
              <td style="width: 19.21%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">ABSTAIN</div>
              </td>
            </tr>
            <tr>
              <td style="width: 42.21%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Steven Hanley</div>
              </td>
              <td style="width: 19.35%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">&#9744;</div>
              </td>
              <td style="width: 19.22%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">&#9744;</div>
              </td>
              <td style="width: 19.21%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">&#9744;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 42.21%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Clara Ezed</div>
              </td>
              <td style="width: 19.35%; vertical-align: top; text-align: center; font-weight: bold;">&#9744;</td>
              <td style="width: 19.22%; vertical-align: top; text-align: center; font-weight: bold;">&#9744;</td>
              <td style="width: 19.21%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">&#9744;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 42.21%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Dr. Mary Jo Gorman</div>
              </td>
              <td style="width: 19.35%; vertical-align: top; text-align: center; font-weight: bold;">&#9744;</td>
              <td style="width: 19.22%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">&#9744;</div>
              </td>
              <td style="width: 19.21%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">&#9744;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 42.21%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">XiangQian (XQ) Lin</div>
              </td>
              <td style="width: 19.35%; vertical-align: top; text-align: center; font-weight: bold;">&#9744;</td>
              <td style="width: 19.22%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">&#9744;</div>
              </td>
              <td style="width: 19.21%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">&#9744;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 42.21%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Yuval Yanai</div>
              </td>
              <td style="width: 19.35%; vertical-align: top; text-align: center; font-weight: bold;">&#9744;</td>
              <td style="width: 19.22%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">&#9744;</div>
              </td>
              <td style="width: 19.21%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">&#9744;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>To approve the remuneration to be paid to each of the director nominees, subject to their re-election at the Meeting.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 36pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 42.23%; vertical-align: top;">&#160;</td>
              <td style="width: 19.12%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">FOR</div>
              </td>
              <td style="width: 19.33%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">AGAINST</div>
              </td>
              <td style="width: 19.32%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">ABSTAIN</div>
              </td>
            </tr>
            <tr>
              <td style="width: 42.23%; vertical-align: top;">&#160;</td>
              <td style="width: 19.12%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
              </td>
              <td style="width: 19.33%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
              </td>
              <td style="width: 19.32%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">3A.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>To approve amended annual bonus terms for Mr. Alex Ovadia.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 36pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 42.23%; vertical-align: top;">&#160;</td>
              <td style="width: 19.12%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">FOR</div>
              </td>
              <td style="width: 19.33%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">AGAINST</div>
              </td>
              <td style="width: 19.32%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">ABSTAIN</div>
              </td>
            </tr>
            <tr>
              <td style="width: 42.23%; vertical-align: top;">&#160;</td>
              <td style="width: 19.12%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
              </td>
              <td style="width: 19.33%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
              </td>
              <td style="width: 19.32%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br>
      </div>
      <div style="line-height: 1.25;">
        <div style="margin: 0px 0px 0px 38pt; line-height: 1.25; text-align: justify;">Do you have a &#8220;personal interest&#8221; (as defined in the Proxy Statement) with respect to the subject matter of Proposal 3A? <font style="font-weight: bold;">(Please note:
            if you do not mark either &#8220;YES&#8221; or &#8220;NO&#8221;, your shares will not be voted on Proposal 3A)</font>
          <div style="text-indent: 0pt; margin-left: 162pt; line-height: 1.25;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">
          <div style="margin-left: 36pt;">
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 42.23%; vertical-align: top;">&#160;</td>
                  <td style="width: 19.12%; vertical-align: top;">
                    <div style="text-align: center; line-height: 1.25; font-weight: bold;">YES</div>
                  </td>
                  <td style="width: 19.33%; vertical-align: top;">
                    <div style="text-align: center; line-height: 1.25; font-weight: bold;">NO</div>
                  </td>
                  <td style="width: 19.32%; vertical-align: top;" colspan="1">&#160;</td>
                </tr>
                <tr>
                  <td style="width: 42.23%; vertical-align: top;">&#160;</td>
                  <td style="width: 19.12%; vertical-align: top;">
                    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
                  </td>
                  <td style="width: 19.33%; vertical-align: top;">
                    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
                  </td>
                  <td style="width: 19.32%; vertical-align: top;" colspan="1">&#160;</td>
                </tr>

            </table>
          </div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <br>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">3B.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>To approve a one-time award of options to Alex Ovadia, the Chief Executive Officer of the Company<font style="font-weight: bold;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="margin-left: 36pt;">
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 42.23%; vertical-align: top;">&#160;</td>
                <td style="width: 19.12%; vertical-align: top;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">FOR</div>
                </td>
                <td style="width: 19.33%; vertical-align: top;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">AGAINST</div>
                </td>
                <td style="width: 19.32%; vertical-align: top;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">ABSTAIN</div>
                </td>
              </tr>
              <tr>
                <td style="width: 42.23%; vertical-align: top;">&#160;</td>
                <td style="width: 19.12%; vertical-align: top;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
                </td>
                <td style="width: 19.33%; vertical-align: top;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
                </td>
                <td style="width: 19.32%; vertical-align: top;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">
          <div style="margin: 0px 0px 0px 38pt; line-height: 1.25; text-align: justify;">Do you have a &#8220;personal interest&#8221; (as defined in the Proxy Statement) with respect to the subject matter of Proposal 3B? <font style="font-weight: bold;">(Please
              note: if you do not mark either &#8220;YES&#8221; or &#8220;NO&#8221;, your shares will not be voted on Proposal 3B)</font>
            <div style="text-indent: 0pt; margin-left: 162pt; line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> </div>
              </div>
            </div>
          </div>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div>
        <div style="margin-left: 36pt;">
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 42.23%; vertical-align: top;">&#160;</td>
                <td style="width: 19.12%; vertical-align: top;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">YES</div>
                </td>
                <td style="width: 19.33%; vertical-align: top;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">NO</div>
                </td>
                <td style="width: 19.32%; vertical-align: top;" colspan="1">&#160;</td>
              </tr>
              <tr>
                <td style="width: 42.23%; vertical-align: top;">&#160;</td>
                <td style="width: 19.12%; vertical-align: top;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
                </td>
                <td style="width: 19.33%; vertical-align: top;">
                  <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
                </td>
                <td style="width: 19.32%; vertical-align: top;" colspan="1">&#160;</td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; align: right;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>To ratify and approve the reappointment of Brightman Almagor Zohar &amp; Co., Certified Public Accountants, a firm in the Deloitte Global Network, as the independent auditor of the Company for the year ending December 31, 2021 and for
                such additional period until the next annual general meeting of the Company.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 36pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 42.23%; vertical-align: top;">&#160;</td>
              <td style="width: 19.12%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">FOR</div>
              </td>
              <td style="width: 19.33%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">AGAINST</div>
              </td>
              <td style="width: 19.32%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">ABSTAIN</div>
              </td>
            </tr>
            <tr>
              <td style="width: 42.23%; vertical-align: top;">&#160;</td>
              <td style="width: 19.12%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
              </td>
              <td style="width: 19.33%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
              </td>
              <td style="width: 19.32%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#9744;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">To change the address on your account, please check the box at right and indicate your new address in the address space above.&#160; Please note that changes to the registered name(s) on the account may
        not be submitted via this method.&#160; &#9744;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">Signature of Shareholder ____________________ Date ___________ Signature of Shareholder____________________ Date ____________</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 38pt; vertical-align: top;"><font style="font-weight: bold;">Note</font>:</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="line-height: 1.25;">
                <div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should
                    sign. When signing as executor, administrator, attorney, trustee or guardian, please give full title as such.&#160; If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such.&#160; If
                    signer is a partnership, please sign in partnership name by authorized person.</div>
                </div>
              </div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div>
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 29!W$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *2EHI, HHHI@%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4449% !129%&10
M M%)D49% "T4F11D4 +129%&10 M%)D49% "T4F11D4 +129%&10 M%)D49%
M "T4F11D4 +129%&10 M%)D49% "T4F11D4 +129%&10 M%)D49% "T4F11D
M4 +129%&10 M%)D49% "T4F11D4 +129%&10 M%)D49% "T4F11D4 +129%&
M10 M%)D49% "T4F11D4 +129%&10 M%)D49% "T4F11D4 +129%&10 M%)D4
M9% "T4F11D4 +129%&10 M%)D49% "T4F11D4 +129%&10 M%)D49% "T4F1
M1D4 +129%&10 M%)D49% "T4F11D4 +129%&10 M%)D49% "T4F11D4 +129
M%&10 M%)D49% "T4F11D4 +129%&10 M%)D49% "T4F11D4 +129%&10 M%)
MD49% "T4F11D4 +129%&10 M%)D49% "T4F11D4 +129%&10 M%)D49% "T4
MF11D4 +129%&10 M%)D49% "T4F11D4 +129%&10 M%)D49% "T444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXE3=]_\ 6G/XE3'W_P!:/8A[0](&J*?XJ0ZJN?O5YNGB5/[_ .M(WB5,_?\
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M47&<UYJ?$J9^_P#K3O\ A)DV_?\ UI^R#VAZ.-57/WJ4ZHH_BKS4>)4S]_\
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M<_>I?[47&<UYH?$J9^_^M/\ ^$F3;]_]:?L@]H>CC55)^]2MJBC^(5YJOB9
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGJ',;8UN;'WC^=-_MR;/WC^=8XI<4*F%S8.MS ?>/YTBZY,?XC^=8YI!Q2Y
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M\_WK.WXI?--.X&JLW'6I$EYZUDK.<U)YQ S0!MK*".M.W"L6&Z)/6KJ39[T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/<<TR@"0N=M,60[NM)FD[T 7X)?>M&*45B1OBK<4WO0!LALTM58IACK4X<4
M/HI <TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ49I10,<1SFD)XI>U--,6XJG%.;FHQ3UI#;#.!3<\TK4VF"),Y%(.*04K<T
MQI-/5N*C-**0#B.<T$YH[4@'-,0J\4-S0:05([Z"YP*;GF@TE,$2$Y%(.*04
MIYI@QK'-*#Q332B@+"XYS2DYH[4T=:!"CB@\T'FE7BD@#.!3<\T&D[TQH?G(
MI!Q0O6E/- AK'-*#Q32*44#L+CG-!/%+VIIH$@4XI3S313UXH!AG IO>@TE
MT/SD4@XH6E/- AI.:4'BFFE I#L+CG-!/%.[8IA%,2 '%*>::*>O% ,,X%-!
MYH/6D[T#1(3D4@XI!2MS0)C2<FE!XIII10.PN.]!/%.[4PT"0*<&E/--%/7B
M@&&<"F]Z#UI.] T/SD4#BD%*W- AI.32@\4TTHH&+CO0QXIW:HS0)"J<&G'F
MF"GB@&&<"F@\T-24#1(S<4T'!IM%(!2<FGAN*CI>:!AGFE)XIM%,0]3@T-S3
M*>.E)@PS@4T'F@TG>@$2$Y%(.*04IYI@QI.32@\4TTHZT!87'>AC3NU,Q0)
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M1FD)R:4'C% #<<T_&*3'>AC0 H&:#Q2*<4,<FE8JPN,\TF>U /%&.<TR0(I
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MVN<MC- &O13$;*T^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0]*I7MT((RV:LS2;$
M)KC_ !+JRQ6[?-CBM(1NR),YOQ?XA C8;J\4US4#=2-\V>:W/%&L&=W ;]:X
M<LSL<FO0I0L<\I7%4^M.QSFF[:?GBNV*T.>3U%W<4W=3328S0Q6N/!S032#B
M@\FDA6 #G-.+<4F>*;WJQIB@\TIYIM.4U0F&<4F.]*1DT9P*D SD8I!Q2 \T
MX\T (>:.E*.*:>M(!<=Z">,4HZ4TBA A5.#2L<TP"EQ36Y0H/%)WHQ13%8=G
M(I!Q2"G'FIOJ(:QIRMQ3"*!05L./6@GC%.[4PT)D[BJ<&E8YIE*#3+0[.!3>
M]+C--/% K$N<BF]*:O6GL.*+DL:33E;BHR*6BX]A2>:7.13:4"FPL XI3S2'
MI0*FXA<XI,=Z7:31VHN 9R,4@XH'6E/-,!I.:4&DQB@"F,=CO2$TN>*::38D
M .#3CS3*<*0V+G%)CG-&*7M0(,Y&*.E(.M*>:=] $/-*#B@<4AZT +CO03GB
MCM2 <T-@ XH/-*W-"\4 &<4F.<T$9-+CBDP#.1BD'% ZTIYHN TG-.5N*8:4
M4#'=\TA/%+VII%"#<53BE;FF"GBA@P!Q28YS012]J+B#.:0<4@ZTIHN 'FES
MB@"D(YHN 8YS03Q2]J:10@0*<&G'FHZD4TQL,X%,SS3B*;B@$A^<B@<4@%*>
M:!#2<FE!XIN*44#L+CG-!/%.[4PB@2%4XIQYJ.GJ:&AL7.!3.^:4TVA("1FR
M*8#BDHHL K'-.!XIE%.P6%[TI.128H(H"PJG%*QS3:*%N,7-)FC%&*+@V.SF
MD'% &*5N:1(UCFE!XIII10,7'>@FESQ32*!(%.*<>:8!3QQ0##.!3,\TII.]
M T/SD4#BD'%*W- AK'-*#Q332B@8N.]!-+GBF$4"0JG%./-,%/'% ,,X%,SS
M2FD[T#0_.10.*0<4K<T"&DY-*#Q332B@8N.]!-+GBFD4"0*<4IYIHIXXI,;#
M.!3>]!HQ36H(=UHZ4 8H;FFQ"'FG!L#%-' I#UJ&QH7'.:1FXIW:F,#3OH"5
MV/A3>XKT;PEHIG:-MM<7I%DUQ(N!WKW7P-I02)-R]O2N.K(Z(+4[7P[9"WM5
M&.U= !BH+:(1I@"K%>7-W9U)!1114E!1110 4444 %%%% !37; IQJM/)A:
M*]S-Q67+)DU+/)DFJA!)JDAK<,9.:E!PN*:HQUH-)ZC8AZT4=:,5-R1ZG%(Q
MS3:*=@"E7@T;:3I0!(3Q4=%&,TM@ 5)NXJ/&**-P ]:*.M&,47 >IQ2,<TVB
MG8 I5XI-M%) 2,>*CHHQFC8 %2;N*CQBBC< /6BCK1C%%P'J<4C'--HIV *5
M>*3;120$C'BHZ*,9HV !4F[BH\8HHW #UHHZT8Q1<!ZG%(QS3:*=@"E7BDVT
M4D!(QXJ.BC&:-@"BC&**: **.M+B@!**** 'EOEH@;;)FFX.*0<&@#=MYMP
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M#@4A 1@5%WI[-3.],$/ZT;:0<4NZDQ"[>*3/:EW\4S/-"8QV,4#FDSD4JG%
M) >*3&:5N:0'%(&&VC&*=36- A>M-88H!P:4\U5P #BD[T[.!3<\T7&AQ7BF
M@9I^<BF]*0,0C%."Y%-)IRMQ1<:&GB@'%*1GFF4[@2$[J<!48.*=NI=26#"F
M]Z<6IO>F"%(P*0#-.SD4**+A<,XIV,C-,?K2AN*12&XYIPXIN>:=G(H$PSNI
M.E XH/- A0,T[%-!Q1NYH8"E:3;3BW%(&I,8AXI<9%,8Y-/5N*%<8S'-*1@4
M'KFESGBF)L:!F@C%.'%!YIBN(!Q1GM2YP*9GF@!Q%(!FG9R*!Q0 =*3&12$Y
MI0>* &]Z?C I,=Z": %ZTTC!H!Q3CS0&P@%&>U+G IF>: '$4@&:=G(H'% !
MTI,9%(3FE!XQ0 W'-.QBC'>E)S0 G6G 8I%%.J7838A7BF <U(6XJ,'FF6AS
M+@4BC)I6;BD1L4 *>*,<9I&/-)OXQ28TA5^=MM=MX-T?S[E?E[URVE6IN+D#
M'>O:/!&C>4T;%:Y*LM#H@CO_  [I0M(D.W'%=2!Q5>VB"1+QVJS7F3=V="6@
M4445!04444 %%%% !1110 5!*^!4Q-4+F3&: *UQ+5!SDT^67+8IA'&:5@$I
M"N:0-DXIXIC0@XI^W(IG>GAN*@&QAZT4'K15B'*,T,,4JG%(QS2Z@-I1S24J
M\4P'%<"F4\GBF4EH "G[>*8*DW<4,",]:*#UHI@.49H88I5.*1CFEU ;2CFD
MI5XI@.*XIE2,>*CI+0 %/V\4P5)NXH8$9ZT4'K13 <HS0PQ2J<4C'-+J VE'
M-)2KQ3 <5Q3*>QXIE):  I^WBF"I-W%# C/6B@]:*8#E&:1ABG*<4C'-+J V
ME'-)2KQ3 <5Q3*>QXIE):  I^WBF"I-W%# C/6B@]:*8#E&:1ABG*<4C'-+J
M VD(S2T4P&!<4\'!HI#0!IVDN *U(VR*Y^&3:16M;S9% %VBD4Y%+0 4444
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M5(",5/,,9BE'%..*86YIWN2Q2,FG=J12,4F>:2W"P8YI3S3CC;3!UJP:$VT
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MQ7TKVG3[<1VZ<=J\VO4Z'3!7+B#"BG445Q&X4444 %%%% !1110 444US@4
M,D?%9-V_6KEQ*!WK*G?<: *QR7S4YYCQ4>*>IH B"D-4@%/8#%(E #",44YJ
M;20!UHQBE7K3VQBA[@1T4=Z.], VT5*,8J)NM) %&,T4]*'L S&**<]-IH Z
MT8Q2KUI[8Q2>X$=%% ZTP#;14O&*B;K20!1C-%/2A[ ,QBBG/3:: .M&,4J]
M:>V,4GN!'110.M, VT5+QBHCUI( HQFBGI0]@&8Q13GIM-; '6C&*5:>V,4G
MN!'110.M, VT5+QBHCUI( HQFBGI0]@&8Q13GIM-; '6C&*<M.;I2>X$=%%
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MK&V*[V%=L8%9&BVGDVJC':MD# KS:LKLZH*PM%%%8]2PHHHI@%%%% !1110
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MG;>,TGH!>MICD"M6,Y K!MVP];4+9 J@+%%%% !1110 4444 %%%% !1110
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M1C%1-UI=W%(:5K %/2HZ<#BC<!7IM*3FFT; .7K3VQBHQQ2[J+ )0.M% IW
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MBFD2Y$2C-*1BGJN*1J;3$F1FDQF@GF@5*3'(DC3!S7+>+>8F^E=6IKD_%?\
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M9>IE3&I7.S'S5(!679ZI"Z_>%:$=PC]#6;B4Y$P&*Y3Q4?W;?2NM)!7BN/\
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MB@=:8!MHJ7C%1'K20!1C-%/2A[ ,QBBG/3::V .M&,4Y*<V,4GN!'110.M,
MVT5+QBHSUI(!*,9HIZ]*& S&*7!I6ZT_^&@"+%&,4X=:<V,4/<"'O6C:28Q6
M?WJ:%\,*8'01'*U)4%L<I4] !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %5KJ0+$WTJS6%K5WY,3\]JJ*NR9;'COQ"U-DG=0>]>0W<AFF+&N\\
M>7/FW+<]Z\_/+5ZE*&ARRD*E2G@4@7 S32V:ZH1L8L3.:2BG <5IT)&TH-'>
MG8P*  \4W-+UI",4(2#-&:4#(I.]%QAFDIY7BF@9-2,<.:1CBEZ48R*4MA(C
M;D5N>%[<RWR@CO6+&NZ7;7>>#]/_ -*1L=ZYJC-HGJV@60B@0X[5TQZ52TZ#
M9;I]*N-Q7G5GJ=$&-S2YI0N12'BL$M32XH/K4%S*L:DYIMQ+Y:YS7):[K?DJ
MV&KHA$ANQ'K^K^4&PWZUYOJWB*0.0&/YTW6]>,I8;JY&YG,S9S79"!E)FG)K
MLC<[C47]MR$_>-9.W-+Y>!FK]F9\QK_VU(/XC4L7B&52/F/YUA!<T%,&GR:#
M4CO--\2R%U!8_G7H.CZP)(URWZUX;;3F(@YZ5TNF>(#$P7=6,J92F>^6%TLF
M.11K.WR#CTK@="\0;V7YZZ:\U 30?>[5'([C;NCROQF,N]>>/PU=_P",7R[5
MPI3=S71!&;8L5=CX2/\ IB_6N.3@XKK_  C_ ,?:_6E,<#W'3#^X3Z5K Y%9
M6EC,"?2M;&*X:AU0V$[TV[_X]C]*D"]ZCO#^X(K.#U%(\M\7'Y'KR2Z/[]OK
M7KOB]?W;FO([D9G;ZUZ=+8YIE?.:,\TI&* ,UT]#)M6%[4@/-.II&*$R ;I3
M#3QS36&*&AI]!UH?]+3ZU[+X1_U*&O&[,?Z4GUKV/PB?W2"N2J;Q/2[4_N5J
M>HK9?W /M4E>?,ZHCA5#5?\ CSD^E7JIZF,V4GTJZ;L*;T/ O%G_ !^O]:Y'
M.7KK_%H_TY_J:X\\/7H4]3FF*XK:T0?O4^M8I.:W=%&)4^M:S5D1%GM_A(XM
M5^E=7VKEO"2YM5^E=5CBO+JO4[*>Q&#S3R?EIN.:D R*R3U-)'!^+)" ]>,Z
MY<L)S]:]E\7K@/7BNMI^_/UKKIHYI,H+<'&:<;IO6JX%*5KMC'0R;)OM!]:<
M+@U JYI2,57(2Y$IN3GK2_:#CK5?%*/2IY N2&Y;UIOFDTA3BD5:J$;"; G-
M(>E2;:&7Y:N6Q*9%#EI0*[SPE9[IU)'>N*L(M]V![UZUX2L-I1L5RU)'1$]$
MTJW$42<=JV.HJK;1[8E^E3[L5YU9G18:QP::#4F,C-,Q@US+<"1<=ZSM3NUA
M0\BI+VX$$><UY_XBU_8&&ZNR$+DMD>MZX4W8;]:X/4/$<GF$!C5;4]8,K-\U
M<],YE;.:[80T,I2-9];D;G)J,:S)GJ:S F12%,5IRF?,:QUJ1>YJQ!XBE5A\
MQK "[J"FTU+A<J,K'I6D>)'8J"Q_.N_TG5A(JY;]:\%M+TPD<UUFD^(BC*N[
M]:R=.Q3D>[P7*N@Y%<UXI(\IL>E9NDZYYBK\U+KMT)83SVHC EL\E\0#,C?6
MN=Z"NA\0G]X:P%&171%$,6V_UPKTSP4<SI]:\VMUQ+7HW@LXN%^M8U1Q/:;8
M?N5^E2&H;5LPK]*G->?-'7#80'FJ6L?\>;?2KH'-4]8_X\F^E*"U"2/%/%A^
M9Z\WE8B4X]:]&\6?>DKST1[Y_P :[T]#$ZGPU:>>Z$CO7M7ART\J!>.U>=>"
MM/W!#BO8=+M1'"..U9U):%):EQ/E6G%LTAXXI*Y&;"BL?5[@1POSVK7SQ7%^
M)[[RE<9K:FC.4CS#Q9?G[2P![UQ4C;WS6UX@F\ZY)SWK% R:[::.>3$I0<4\
MK@4T#-=,=C%L>.:1C1TI=N15"1'2YHQS2D8%/8!,TE*!F@C%#  :=CBD XHS
MVH$Q":0&G$4@&:!CAS2'K2]*7&1F@20G:D!YH]J7&*0"'B@<T#FCI0 9YI>U
M&,\TF>U  .30>*7&*0<T *.:::7I2XR*8#.].%-QS3\8%(; \4HY%-ZT$X%2
M]@1&2=^*Z3PQ:F6\7CO7/P1^9,![UZ3X.TS=<(=O<5C5DDCHBCU?PMIXBBC;
M':N\0805C:/:>5;)QVK:'2O)J.[.F"LA:***S+"BBB@ HHHH **** $8X%9=
M]+BK\S8%8]X^XT 5"VZC%-'6I0O%*X#**4]:2BP!0*<HS0PQ1U 3=Q2&BE'-
M,!M.!Q3BN!3*2 4G--I1UI^WBA@,'%+NI#UHI@% IRC-##%+J F[BD-%*.:8
M#:<#BG%<"F4D I.:;2BG[>*& P<4N[-(>M%, H%.49H88I=0$W<4AHI1S3 ;
M3@<4XKBF4D I.:;2BG[>*& P<4I;-(>M%, H%.49H88I=0$W<4AHI1S3 ;3@
M<4XKBF4D I.:;2BG[>*& P<4I;-(>M%, H%.49H88I=0$W<4AHI5YIL!M.!Q
M3BN*920"DYIM**?MXH8#.E*6S2'K13 *!3E&:&&*74!-W%(:*51FFP&TX'%*
M5Q0HS26P"$\TFZG,,4VA@&:7=FDI.E  :5#AQ3E&:;C#"A/4#=M&^05;'2LR
MTDX K24Y%" =1113 **** "BBB@ HHHH **** "BBB@ HHHH **** $/2N%\
M7WODH_/:NXD;"FO)_B#=[ _/K6M):F<V>/\ BF[\ZX;GO7, \UHZM(992<]Z
MS5%>M3V.29/NR*810*<>:Z$97&4X&DQ1BGT 7'>ESVHSQ28YI" <4IYI#S2C
MBD@#.*;GFG$9IG>@:)-V12=*:*<>13$QK'-*&P*:1334RV*19L5\R[4>]>N^
M$K';L;%>6:)"7OD^M>Z^&K/9;1MCM7#59M$Z^ ;85'M3B<TB\(!0*X*CU.B"
M'J<4./ES30.:=<L$MR32BBF<[K=Z((6Y[5Y/XAUGS&<!JZ_Q9J8$;J#7C^HW
M323-SWKNIP,),K74QE8\U HH&33PM=D(F4F*!2L>*.U-(JTC.]P4X-.ZTP"I
M!Q0T,8>*6)BKYS0PR:.U9N-QIG2:3JQ@<9:NM3Q$'BQO[5Y<K,K9!J_!=N/X
MC1R%<VAK>(;O[02<US6<5<NIB_4U2-4HV(N(/O5U_A$_Z6OUKD$^]78>$5_T
MM?K6-1&D6>YZ2?W"?2M8UD:5_J$^E:_:O.J;G5!@&Q4-YS":DQS4=W_J#406
MH2/,_%Y_<O\ 2O(;DXG;ZUZYXO\ ]4]>0W7^O;ZUZ%.6AS2(B<T XIO2BNM2
MT,VA^:3.:3/:@#FIB9V%Z4'FD8T*>*J4M!I#K7BZ7ZU[%X1_U:5X[;\W:_6O
M8?"'^J2N2H=$#U"V/^CK]*=3+;_4+3\9K@DS="]:J:F?]"D^E7 ,52U0?Z%)
M]*=/<<EH>">+?^/Y_J:X]OOUV'BW_C^?ZFN08?-7IT3FF)G%;VBG,J?6L!JW
M=$XE3ZU=1DI'NOA'_CT7Z5U!KE_"/_'HOTKJ#7E5GJ==/8!R:=]U::O6G-RI
MK*.Y3."\7G(>O%M<;$Y^M>S^+> ]>*Z[_P ?!^M=U(YYF8*7--4\4M=T68L>
MIQ2GYJCIX.*TNB&)TH'6@\TV@+DA/%-!P:;FE'-"!C]U!;C%-Q30"6J9NR"*
M-318=]ZO'>O;/#-MMB0XKR7PY;%KM..]>XZ%;;+9#CM7#49TPU.A3A!]*:>:
M?CY128Q7!-W9NA5/:DE^1-U*!SFJ^I3"*U8^U*$;LF3L<MXCU410L-U>0ZWJ
MIF=AN[UU/BS4L[U#5YE<2M)*W/>O1I0T,I2(I&+MUIHXI0*7%=*5C%L<&I2<
MTS%.45<40V .VD9MU$@S3 ,5?*AIZ!S5BVF,<@.:AQ2=*RE&Y2E<[72-:\L@
M;JV+W6A)%C=VKSFWE:-LY-7S=LR]:E1!L=J\OG.364#@58FDW56:KL3<FM^9
M!7HG@W_CX7ZUYS;']X*]'\&#_2$^M<M0T@CV2TXA7Z59-5[;_4K]*GKAGN=<
M1 WS53UD_P"A-]*LX^:JVLC_ $%OI1#<<CQ#Q8WSR5R6FVOGS].]=;XI4F62
MJ/A>Q,UP..]==]#!K4]'\&:?LC7BO1(?W:8K!\/6GD1+D=JW7ZUS59:%Q%8Y
M--ZT#FG!:RCJ:-D$S[$->5^-+_8S#->AZQ=BWC;)KQ7QE?\ G2M@]Z[:43"1
MR5]-YLA.:K"D.6.:=VKJBCGD]12<BDZ4@ZTIYK9$,0FGJW%1FE%6D XCO1G-
M!/%(!S0Q"]*.M!YH'% !G IF>:4TE T/SD4=*1>*5N:!#2<TY6XIAI12&.(Y
MS1G-&>*0<&F(!Q0>:#S2CBD 9P*9GFE(I.],:'YR*0<4**&- @/-+G'%"FD(
MYH ,=Z4G-&>*0#F@ Z4QCFI&'%1X^;%9ME15R[I<>^[0>]>X>#=,PL;[?2O)
MO#NGM+>1G'>OH;PK8^79QDCM7%6EH=$%J=?:)L@4>U6*9&,(!3Z\YG4@HHHI
M#"BBB@ HHHH *1C@4M1RMA: *EU+@&L>:7)JY=29S6:REC0 JG-3!N*B5<4_
M%2T AZT44;:=P'*<4,<TVBG8 I5XI-M%) /)XIE%&,T;  ZU(&XJ/&**-P ]
M:*.M+MQ0 Y3BD8YIM%.P!2KQ2;:*2 >3Q3**,9HV0 *DW<5'C%%&X >M%'6C
M&*+@/4XI&.:;13L 4J\4FVBD@)&/%1T48S1L@ 5)NXJ/&**-P ]:*.M&,4 /
M4XI&.:;13L 4J\4FVBD@'D\4RBC&:-D "I-W%1XQ11N 'K11UHQBBX#U.*1C
MFFT4[ %*O%)MHI(!Y/%,HHQFC9  J3=Q4>,44;@!ZT4=:,8HZ@/4XI&.:;13
ML 4J\4FVBD@'L>*16Q3:,9H>P#F.:;1C%%-; %%%%)@.4XI&/.:2D/2BU@+%
MO/AP*W86R@KEXLB4&N@M904 I@7:*0=*6@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH I7TPB0Y/:O$OB+>AB^#ZUZIXENO)A8@]J\#\:7YF=^:ZJ*,*
MAQ$[[V.:@[TA8DT"O3I')(D[4B]:04IXK6Y IH'2A>:0]:J^@>0G>G'I1VIO
M>IN HZ\TIH/%(.:+@/7I3".:,XI>U*X[AVI%ZT@ZTX\"B(A&I@^\!3LYI$YD
M%$MC2*.D\-P;KV,X[U[YH<(6Q3CM7C'A>WS<1G%>WZ2NVR3Z5YU9FT"_112U
MPLZH["KC-5-7G$=BQSVJ=S@9KF_$=[LL7&>U;01,CRKQ5J)::1=U<$[%I"3Z
MUK:Y=M)?.,]ZR<<YKT(+0YI,<!4@X%-04,<5T):&38F?FIYZ5%WIV:HD5.M*
MYIO2D)S3L-CQTIO>D!I_:E;438'&*1&P::324[ /=\T@Z4VC-2Q"I_K*[/PE
MC[4OUKBU^]78>$6_TQ?K7/4-8GN>E?ZA/I6M63I7^H3Z5K=J\ZIN=4!RXJO>
M_P"I-29YJ&[Y@-91W*9YGXO_ -2_TKR*X'[]OK7K_BN)GC? ->575I)YS?*>
MM=E-G/)&<PI1TJVMG(?X333:2 _=-=*9FT5,'=3STJU]BDQG:?RIGV27/W3^
M54I6%RE2@U<^Q2?W3^5(;*3^Z?RIN12B06G_ !])]:]A\(_ZM/PKR:UM)!=+
M\IZUZ[X3B98TR*YJDBXH],MO^/<?2I%ZU%:_Z@5+TKAGN;QU'FJ.I_\ 'E)]
M*N9JCJA_T*3Z4X;CDM#P7Q9_Q_O]37)/UKJ_%G_'\_UKDLY>O4H[')-#>];N
MC?ZU/K6&_ K:T0_O4^M.JR8GNWA'_CT7Z5U!KE_"'_'HOTKJ#7EUMSMI[#:>
M#Q3*"< UE'<I['#>+QP]>+:XA\\_6O;O$\9D#<5Y'K-A(TYPIZ^E=<'8PDCE
ME0YJ0H<5IKILF/NG\J/[/D_NG\JZHS,91,M4.:&4UJ_V?)_=/Y4G]G2?W3^5
M7[34FQFJIQ2%#FM0:?)_=/Y4XZ=)C[I_*K50:B8Y4TJ\=:T'L9%ZJ?RJG<1F
M/M5J5V*41.#1&,RBHHVS4UN,W"_6HJ,B*LSN/"MMFX0X[U[;IL86T3Z5Y3X4
MM_F0X]*];LABV4>U<%5G5!%I:1^M-S29KC;U-B4$!,USOB*\"6C\]JVIWVQ$
MUY_XIOR(7&:Z*,=3.H>:>(+TR3N,]ZYE>6.:MZE.9+I_K5(5Z=..AS28]J!3
M2:!UK22T(8_%.IO:D!YHBB!],(YXI6-"\U8(!TIN.:4]:7M28UH*>!2*YII-
M-%*Q70>Q)H[4"D:DQ#K;_7"O2_!G^O3ZUYI;?ZT5Z3X,/[]/K7-5T-X'LMK_
M *E?I4YJO;?ZE?I4]>94>IUQ%4<U4UK_ (\6^E7%ZU1UK/V)OI3@#9XSXAB\
MR9P!WK0\%6'[X$KWHO+?SKM@1WKJ/"]B(F4XK=O0GE.TM8A&@QZ5.:%&%I#7
M/4EH4D(O6I68*M0]#56^N/+C//:G31,CD?&=_P"5&V&KQ76+HSRGG/->@>-]
M0+!@#7E\DAD8DUZ-*-T828B?=I.]'2DKJC&Q@QYZ4B^](*4\4UH0#=:4=*!S
M335 &>:<>E,IP-/8&*/>D8\TK<4PTF"'CI3<<T"G=J38; >E(II":04QV',.
M:4=*!S330(,\TX]*93AS0#!?>ACS2MQ3#0"'C&*3'-(#3^U- (>E--*#S2L*
M$P&BG=J *0GFA@)WJ04WM2 \U-P'T1IOF4#UJ-S6CI<!EN$X[UA-FD$>A^#M
M+WM&VVO==%MA%:*,=JX+P3IB_9D;':O3+5/+B KS:[.NFB>BBBN8V"BBB@ H
MHHH **** "JMR^$JPYPM9MW)\I%)B9G2OEC34 IK'+&E!Q26PQ6ZTX8Q3"<T
MF338#OXJ<V,5'FEW46 3O1WH- IW E&,5&W6C=2&E:P!3TJ.G XHW 5Z;2DY
MIM&P#EZT]L8J,<4NZBP"=Z.]!H%.X$HQBHVZT;J0TK6 *>E1TX'%&X"O3:4G
M--YHV <O6GMC%1CBES18!*!UH- IW E[5&W6C=Q2&EL 4]*CIP.*-P%>FTI.
M:;S1L Y>M/;&*CZ4N:+ )0.M!H%.X$O:HCUI=W%)2V *D2HJ<#BC<!7IM*3F
MF\T; .6GMC%1CBES18!*!UH- IW E[5$>M+NXI*6P!4B5%3@<4;@*]-I2<TW
MFC8!Z4YNE1]*4FBP"4#K0:!3N!+VJ,]:-W%(:6P!4B5%3@<4;@*]-I2<TWFC
M8!:***8!2&EHI,! .<U?M'.[%4!UJY:_>H0&XA^44ZHHS\HJ6F 4444 %%%%
M !1110 4444 %%%% !1110 4US@4ZH+E]B9IK5B>QQ/C:Y\NW;GM7S[XBN/-
ME?GO7LWCV]Q XSVKPC49?-E;ZUWT8V.:<C/C7-/VTB_+3\UWQ5CFDQN,4@YI
M2<TG2M"0/%+C--8YI0: #/:EQQFDQWH)XI '6@\4@.#3NM "=:,T=*;GFD \
M"ANE -#4D'493X1F9?K3*EMO^/A?K2GL:1/1_"D&7C.*]CT]-MHOTKRKPG'P
MAKU>R;_1E'M7FUF=,$3=Z6FG@TY>:Y%J;I!,N(&/M7FGBR^VHZ9KTB[DV6S_
M $KQOQ=<9F?FNJDC.H]#S;43NNV;WJ!!FI+D[IS35&*]"".23%/RT8R*0\T9
MP*U9 W'-.QQ3<\TI;BAL!1R:&&*13@TXG-4@&@4N><49Q3<\T,5AY7C-, R:
M?NR*3I2N#&D8-*%R*0G)I0V!2D-"#[U==X2XNU^M<B/OUUWA/_C[7ZUA,V@>
MYZ0<P)]*USTK%TDX@3Z5LYR*\VLM3JBA.])(F],4M**Q3*:.;U?1Q.A^7K7(
M2>% TA.SOZ5ZA, ZXJG]E7/2MH2,VCSG_A$P/X/TI/\ A$0>=GZ5Z/\ 95]*
M46J^E;\Y'+J><#PF.FS]*7_A#UZ[/TKT?[(N>E.-LN.E)U Y#S=?"*_W/TI&
M\(+_ '/TKT;[.H[4OV96[4>T*Y=3S:+PD%E!V=_2NQTG21;HORXQ6M]E4-TJ
MW&@5>E92E<:B.C7:@%.I,T5@WJ:I6%JIJ:YL9/I5NJFI'_09/I6D-R)'@7BW
M_C_?ZFN1;AJ[#Q:/].<^]<<YRV*]"D]#DJ"$YK=T48E3ZU@GBM[13F5/K6D]
M28GN?A$_Z(OTKJ!R:Y/PFW^C+]*ZL>M>966IU4V2%>*CQFG!]W%#?+6*W-C'
MU&P%QGCK7.7/A19GSL_2NVR&-/"KZ5K&6IFT>?\ _"'K_<_2D/@]?[GZ5Z%M
M7TI"J^E;*=C/E//1X04_P?I3O^$/7^Y^E=\$4=J=M7TI.H#B>?\ _"'K_<_2
MC_A$5_N?I7?D+Z4!%/:KC4!1L>7ZIX56&(ML[>E>=:W8"$MQTKWWQ JBV/':
MO%/%! 9ZWA,SDF<2/E-7;!=UROUJF!EJTM-3_24^M:LS6YZQX4@^1#CTKTNW
M7$"_2O/O"PQ$AKT&!LQ"N&L=,"0#)H(Q2KQ0QKCMJ:%2].VV8^U>0^*[S]XZ
MYKUC4Y-MH_TKQ'Q5-FY?GO7=0,9,XJYYG8^],49HE;,AH4XKTJ>QRR C%."\
M4=:7.!3DA(;WI<8I.^:">*I(&A>M'2F@XIW6GU$&,TF>:7.*3%2P0I7BF@4[
M.:3I20V'2EQD4G6E)P*3V!!;_P"N%>D^#/\ 7I]:\VMS^^KTCP8?WZ?6N2L=
M$$>SV@S"OTJ=A@U#9G$*?2IF.:\RIN=,1Z#C-4M67=:L/:K0DQQ4-X/,A/TH
M@RF>?_8=UV3CO74:1;>7CBH8[/,Y..];$$?E@5JWH%RV>*4#(IH^:G@XK"3%
MU&,,5SGB.Y\BW8Y[5T%P^R,FO/\ Q=?_ +AAGM6U$B9YQXBO?M#L,]ZY,C!K
M1OY]\K<]ZSB<UZU%:'--BXXIO>G T8[UN87%Q@4@YI<YI.E(!>E&,TTG-*#3
M 3'-.QBC'>D)IL!>M-(Q0#BG=:0;" <49YI<XXI,=Z3 "*0#-.SGBCI3 .E&
M,TTG-*#0 F.:=C%&.](338"]::1@T XIW6D&P@'%&>U+G'%)CO0 N,4#FCK1
MTIB \48SS32<TH/%(89[4'BFYYI<Y%2]!V$'S-78>&['S)8SCO7)(/G%>J>"
M-/\ ."-BN6I(U@CUKPE:^79KQVKK5&!63HD'D6ZC':MBO,J.[.R*5@HHHK,L
M**** "BBB@ HHI#TH BF;"&L2XERQ%:=S)\I%8DO,E "=Z6@44  ZT_;Q3.]
M2;N*3U C-%!ZT4P'*,T,,4*<4,<TK:@-I1S29I5XI@.*X%,IY/%,I+0 '6G[
M>*8.M2!N*'J!&>M%!ZT4P'*,T,,4*<4,<TK:@-I1S29I5XI@.*X%,IY/%,I+
M0 %/V\4P5)NXH>H$9ZT4'K13 <HS0PQ0IQ0QS2MJ VE'-)FE7BF XKBF4]CD
M4RDM  4_;Q3!4F[BA@1GK10>M%,!RC-##%*IQ2,<TNH#:4<TF:5>*8#BN*93
MR>*926@ *?MXI@J3=Q0P(SUHH/6BF Y1FAABE4XI&.:74!M*O-)FE7BF XKB
MF4\GBF4EH "G[>*8*DW<4,",]:*#UHI@.49H88I5.*1CFE;4!M*HS29I5XI@
M.9<4RGL>*926@ .M/V\4P=:DW<4,",]:*#UHI@/49I&&*%.*1CFEU ;5FT;Y
MZK'I4ML</3 Z"+[HJ6JL$F0*M4 %%%% !1110 4444 %%%% !1110 4444 %
M9^IOL@)]JT*Q=>EV6K'/:JAN)['D7CVZW(XS7C<KYD;ZUZ3XUNMYD&:\P8YD
M/UKU::T.*>X^ESQ2+TH(KI1CNQ!UIYY%-I157*<>HPBE I6I5Z4R;AVII%'>
MG<8I"&"GKQ2*.:&-,&*1FF8YJ5>E,(^:D4(!BG=:4]*1.M2D%AN,5+:_\?*_
M6F24^S_X^%^M3(N)ZWX3'[M*].LQ^X%>9>$ON)7J5H/]'%>=6.F YAFG1C I
M:,C%<BT.E/0I:D?]&?Z5XKXL?]^_UKVC4C_HS_2O$?%K?Z2_UKJI'+4>IPLI
M_?FE)R*9-_K32H:]&!S3'#BD-*U Z5O8S\QE+M.*/XJD.-M0T414X4G>E-6D
M,0BDIXZ4W'-)DW%%*>:#TH0\TK M1A&*,4]Q2KTI2&,7[U=;X2_X^U^M<F/O
MUUOA/_C[7ZUA,V@>X:2NZ!/I6SMVBLK1<"%,^E;4F,<5YU9ZG7'8A--W4X]*
MBP=U<Q1+C-*%I?X:%/--,BP;11@4K&FUHI D+Q28I,TN:38]QI7-*HQ3EI'/
MI24@V%*@TAZ4Y#Q36I-A'<9CFG=J2E%+<MBU2U,?Z')]*N55U+_CQD^E;4UJ
M939X+XM_X_7^M<:P^>NP\6G_ $]_K7(R?>KT*:.69&W-;NB<2+]:PN];^C?Z
MU/K5ST1,3VWPFI-LOTKK,?+7,>$<?95^E=2>E>;5W.RFB*/(:I93D4SO2]:Y
M[ZF@Q%-2;33EQ3CC%5<AD=&*.]//2J;$D,Q2'BGK37ZTKC:&;233UIR@8I!]
MZJC(&8OB(?Z*?I7B'BCEWKW'Q$1]D/TKQ#Q-]]_K772U,IG&)PU:NF<W*?6L
MH_>K3TK_ (^D^M=,MC!;GLWAA,P)7=VZ$1BN,\*K_HZ?2N[0 0BN&LSI@AE'
M:CO2]JYEW-68NLG%J_TKPSQ/)_I;_6O<-<.+63Z5X1XFS]M?ZUVT4831S+_?
MI0,T'[U/05Z,-$<S <4AZTKT@JT2EJ%(12]Z5NE-@V,ZT\<4BT,:5R0/)I>U
M Z4@/-)H!<8H/-.;[M-0\T%6#I36&13GZTO\-2T"W&V_^M%>D>"Q_I"?6O.+
M?_7"O2O!F//3ZURU%H=%-GLEK_J5^E3GI4%J?W*_2I^M>;46IU1V(2#NI[#<
MF*=BE'6H3&54A ?.*G*Y'%2L!BFKUJKF8(,"E/6AJ :S:-(HJ:AD6YKRGQ<Y
M"/S7K%^-T!KRKQC"WEOQ711W,I(\HG?=*WUJ(5).I65L^M1@YKUJ3.6:' 4[
M/&*<.E,[UL9- !S0>:4]*1:5A#32@4K=:4=*8[B]J812@\T]NE )$5/'%(M#
M=:! 1S2]J!TIO>DT HX-*>:#TI%-,!N*4"G&CC%/H%PSQ32*,\TX]*0;#!3Q
MQ2+0W6@&!ZTN>,4#I3>] #AUI&-./2F56X"4N*2I!C%1)E$>*7I2_P 5)*>*
MB;T&BU:0F:1<>M>Z?#RQQ"A([5Y#X:M#<2KQGFOH/P59>3 N1VK@K2L=$(G9
M6T>Q0*M"FJN!3JX&[LZ(JP4444B@HHHH **** "FN<*:=5>9\ T";*%T_)K-
M?[U6[A\L:J'K0,04M%%*P!1113 .M+MH7K3VZ4GN!'11WH[TP%VTE2CI4;=:
M2 2C&:*>E#V 9C%%.>FTT =:7;0O6GMTI/<".BCO1WI@+MI*E'2HVZTD E&,
MT4]*'L S&**<]-IH ZTNW%"]:>V,4GN!'110.M,!=M)4O\-1MUI(!*,9HIZ4
M/8!F,44YZ;30!UI=N*%ZT]L8I/<".BB@=:8"[:2I?X:B/6D@"C&:*D2A[ 1X
MQ13GIM-; '6EVXH6GMC%)[@1T44#K3 7;25+_#41ZTD 48S14B4/8"/&**<]
M-IK8 ZTN,4JTYNE)[@1T44#K3 7;25+_  U&>M) )1C-%2)0P(\8HISTVFM@
M#K2XQ2K3FZ4GN!'0**!UIV 7;Q2Q?>IW:FH</20&M:=JT1TK-M&'%:(Z4P%H
MHHH **** "BBB@ HHHH **** "BBB@!&Z5R_BB;99M]*Z:0X0UQ/C&;;9/SV
MK:DKLSF[(\-\57)>609[UQ*C+&NCUV;S+B09[USO0UZE-'')CNAI^/EJ+/-.
M#<8KH(0AZTM(:4<TD4]@'-!X-*>*,9IV,P[4@ZT9[4N.]" #3*D'-(RXJDAH
M:#3J0"C-2Q!GFEZ4 4N*07(V.:EM#_I"?6HF&*FM!_I"_6HF:0U/7/"7W$KU
M.T_X]U^E>5>$C\J5ZM:?\>R_2O.K:'7! YQ2*2:>5W&G+'BN6YJV9VI?\>K_
M $KP[Q:?]+?ZU[OJ*?Z(_P!*\,\7IB[?ZUTTC"2."D_UAI1Q2N/WIIVWBO2I
M['-+<9FC-%."\5J0]!M+FCO2XXH"XE%*HS2L,4[ZC&YIW:F@4N:EZDB&D!IQ
M'%(!DTQICAS32<4IXI<9%1(%N,7K77^$?^/Q?K7(+]_%=GX17_2E^M85&;1/
M;=,)6!,>E:RL6%9FE+N@3Z5L>7@5YM;<Z8,CIVT8S2'B@-VK T8TDTF34A7C
M-(JYIVT)$!I:4C%**J*T*3&$4E/HP*&KB&YQ3<YI^,TF*FSN# 4&I%7BF-UI
MI#3(P>:?2;:=0T4Q15'5/^/*3Z5=JKJ2YL9/I6U,SD> ^+?^/Y_K7'L?GKL?
M%H_T]_K7'N/FKOIG+/<8:W]#YD3ZUS[=:Z#0O]:GUJYH43W#PF<6R_2NJ/W:
MYCPFO^BK]*ZG'%>=5W.J! "=U2=J4ICFFUSV+;%R:7)H %!*CO5*) M&:3<O
MK2[E]:I1'<#Q2=:-R^M&Y?6CD>X-@#2TFY?6@.N>M-(ELQ/$)/V8_2O%/$_W
MG^M>W>(=OV4_2O$_$X!=_K7716IC)G&+RU:.F<7B?6LX<-6GI8S=(?>NR2T,
MXO4]P\*_\>J?2NT1OW8KB/"S?Z,@]J[>/_5BO+KLZ:84\?=-(@R:<_ KG@]3
M9G.:Z?\ 1Y/I7A_B1?\ 2G^M>Y:VN;=_I7B7B5?]*?ZUZ%)'/49R?\=// J-
MCAS2ELUW1.9@3FDI*E"\59(RC-*1S01Q5,0W-&:4#-(1@UGLP%I*>%XIN.:J
M]QAGBD!Q3RO%,[T /'-(QI <4XC(IM"ZA;_ZVO2/!9_TA/K7F]O_ *ZO2O!8
M_?I]:Y*QTT]CV* _N5^E3I45JN85^E3XVUYE0ZH; :3.**:YP*R&V.+4F:KB
M49ZU8C^:JZ&8N:;GYJD(Q3=O-2S6(V==T-<!XLL]\+<=J]";E<5S^N67G1'C
MM6U)D5$?/&K6QBD;CO67'7=^*-,\LN=M<0R;&Q7ITI:'+(7-+VH R*3O71N<
M[ =:#Q2XQ2#FF(4<TAI>E+MR*8(CIP.:3O3L8%#&P-,-2#FFL,4@0@IW:D X
MHSS0Q"$T@IQ%(!FF,<.:1J4\48R*!#.].%-QS3\8%(;$/% YH'-. I"&]Z7'
M%!%)GM5( !YH:EQB@<T (HH)I>E&,BI8T1YI.6.*&ZU=T^W\Z0#%93+1WG@#
M3_-D3(KWW1+401*,=J\P^'NF["AVU[';1>6@KS*\M;'7374L4445S&P4444
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M88I=0#=3<XI:!R:8%VQ<[JV4.16+:C::UXCD4 34444 %%%% !1110 4444
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M;_ZE?I5A:\^H=T-AI/-07C^7"6JQMR<U1U<[;-OI4)"D8BZG^_*Y[UN65SO
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MQ\X#6S#VKRWQ999WMBO3V.4(KE/$UD&M';':NFE(PD> WZ;+AA[U47DUK:U
M4NGX[UCJ<&N^#T,6B8BHS3P<BF-UJXNS,[:@IYJ0D8J'M0&-=$5<+#QUIU,H
MS2DB;#Z8:,FDI)V&D%/0U'0,T-C18XIK$8I@)Q43L<U!21/;G]\*])\&?Z]/
MK7FEI_K17I?@S_7I]:Y*IM ]DM?]2OTJ?O4%M_J5^E35Y]0Z8LD4C%9FM_\
M'HWTJ[N.ZJFL#-DWTIP$]#R#6)C%.YSWK8\'ZB#* S=ZYWQ,VR5ZH^&]1,4X
MY[UO;0ROJ>_P2B51BI3Q6'X=O!<1+D]JW7ZUSU$:18@ZU)P!4=)DUE%%2([B
M)94.17D_C73AO8JM>MG[M<=XDL1,CG%==*5C*2/!;R(QN0:JCK6]X@M3%<,
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M*[HLQ:$(Q0.M.89H'%:W,V.[4SH:?FFM5$H0\T#B@4'K4C CFE[4#I2=Z=@
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M^E1#123]W]*]3DT)2?NU&- 4'[M:>T#E/,_[#_V/TK;TO0%;&4_2NV70%/\
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M+5Z[97(E0<U\[>'K_P"QN#G%>I:/X@#1CYJY*D+F\9'HF5ZYH\Q<XS7(-XB
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MD'%*>:8F-)IRM3"*4"@8_'>@GM2YXQ3.](8=*<#FFGFE'%") FDQ01FE[4;
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M['2FE8'!YJ)3L5&)2BMR>U6UTXN.E=/9^'78#Y36U!X<8#[M8RJ(OE//SII
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M<W-(.E*O(I&ZT)@QO>G'I1VI!UHN(%I&ZTIIM"!#_P"&B ;I<4PGBI]/7?<
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MUH#811Q1FES@4SO0 XCBD R:">* <4 ./%&,BFDYI0: L-[TXCBEQWI": $
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M;,5'WKAD]3HB.DYJ(<4_--(R>*A;FG0>!F@BA3BG&G8+#5.*'.:0T5-]26A
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M04XCBD49H'<<M(U!XI<9% B.G+1CFG8P*!L&IAIPYI&&*!(!3OX:0#BC/.*
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MU&"*]$\$C)2N6ML:T]SV32S^[%:1;BLS2QB,5HD5YLSKBQ,\T%LBFTI'%2K
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M^E6S7G5&="1*,;:B/6ES25B: :>E1XI<XJ7J YNM+VIE%,&.7K3FZ5'2YHL
ME ZT8HI@2<8IG>DW4AI("[;8)K6A&!619 EJVHQ@4P)**** "BBB@ HHHH *
M*** "BBB@ HHHH *R-:BWV[#VK7JE?IOB(]JJ.XI;'@?CFTP)#BO*"FV0_6O
M<_'UIMB<XKQ*Y7;*WUKTZ+.65Q@&132.:%:G8[UV19SL4"EZTW=2;J;(LP/%
M*!FFDYH!IC#'-.Q@48[TA-  .:1AB@'FG=: V$449YQ2YQ3,\T /(XIH'-+G
M-+TH #Q0!D4TG- - 6#'-.Q@48[TA/:@ '-(PQ0#S3NM ;"**,\XI<XIF>:
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ML"H@&*N;!BF!,-4XZ5CS7-U&R.=UH?NV^E>%>,_^/EOK7N^N<1M]*\(\9?\
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MTG- -(12@4#'8[TA-+GC%-(H$@!IW6F 4\<4#8F<4W/-./--[T AP.>*7I2
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M' H6D:@7D)GFG'D4SO2K0-H5>#0QI6IAH$AZGBFXYI!4G:@-A">*13S2&D%
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M#0%@QS3L8%&.](30&X#FD84 T[K0&PBCBC/.*,XIN>: 'D<4U1S2@YXI>E
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M85FBQC->;^(]&W;B%KHISU,7$\:D3RSBF@YK:U72WB<\5BLOEG!KNIS,I1'
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MI&I3Q1C(H$,[TJT8YIV,"@;!J8:<.:1A0)""I.U-4<49YQ0#$-(*>1Q35'-
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M:4<"A:1J!>0G>G'D4SO2K0-H4#FAC2FF&@2'J>*;CFD%2=J V$)XIJGF@TE
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MEIK4IXI<9% B.GKUI,<T[&!0-@U,-.'-(PH$@%._AH XI,\XH ::*<PXI%%
M[Z#EIK4IXI<9% B.GK28YIQ&!0-@U,-.'-(PH$@%/[4@'%)GG% ;B&DI^*7%
M(+C*,T,*2K3&+2J<TVC.*F0Q7X/%=5X;OVAE09QS7*_>J]8W!AG3GO7+45S2
M+/ISPC?"2T7)[5V4;;ES7D'@G4_W*+N[5ZO8R>9"#7FU8V9U4V6Z***P-0HH
MHH **** "BBB@ HHHH **** "BBB@!#TJC=GY:O&J%]PM &2_6F4N<DT&FT
MF:**5>32 3%%2%>*:!S20,;24X]:<!Q2; 91FE;K250!BBGJ*1A1<!,TE. X
MI!UI!<3FBI".*8*2V'82B@T['%.P6&T9H-%,044Y1F@CFE8+C<FBG8XI!UI
M)13V'%-%-#%III>]/QQ28,CHS0>M%4(**>@S2.,&E;4!N:**5>31L F*,XJ1
MAQ4=5N 9HYH[U)MXJ9 14N:.]+BE$=A**4"CO56#H'-(:?CBD'6FF2,%+FGL
MN!314O4:0E%%. XH3!Z"4IZ4#K3F'RUI%ZB;.#\7_=>O%]<_UQ^M>U>+1E7K
MQ77N)C]:]"F[HY9HQUJ1ONU&O2G9KIMH8VL3V?\ K!]:];\$=$KR>S'SCZUZ
MQX(Z)7/51I!GJ-O]RGMUJ.W/RBI\9%<$SJ3T&4Y:3O3CQ6)3$:FT[K2&BP[:
M!FDI<4#DT-CL)13V&!2 9I=!#:*4CFEQQ0*XVC.:#13L,****+ )2/TIU&,T
M(!D0)-:5O'TJ""+FM2WBQ1U GA7 J:FJ,4ZF 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 UUW
M+BN=US31<P,-O:NDJ&>,.O2KA*S)DKH^>O%N@?9][!:\PNHS&YXKZ7\7:/\
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MD4\TAZT@I#L.;DTHX%"TC4"$SS3CR*CIRT#:%7@T,>:5J90)#P>*3'--%/\
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MW0*?:IQ6?I<H>T0Y[5H5YCW.J.HM%%%26%%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@4(!S* *KN<5+(_%0#YS3 DA^8U?A@S4-O#R.*U8(L"@!T,( JR!@4*,"EH
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M>P#2,4E.>FTT #FEVXH6GL>*3W CHH[T#K3 7;2&I0>*B/6D@"E"YI*>E#V
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M32:=GBFD4A( <4X<TT#-.'%,&!.*9WIQ&:2@:%!S2GBD Q2GFD(:3F@&@C%
M%,8['>FDT[/&*:12$@!Q3AS30,TX<4P8A.*;WIQ&:;0-#@<TIXI ,4IYI"&D
MYH!H(Q0!3&.]Z:33L\8II%(2 '%.'-- S3AQ3!B$XIO>G$9IM T.!S2GBD Q
M2GFD(:3F@&@C% %,8[WII-.SQBFD4A( <4X<TT#-.'%,&(3BF]Z<1FFT(:'
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M,>:2B@!X/%-[TF:* L/)XI%/--HH"PYJ4'BF44!87O3B>*910%ARTC'FDHH
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M& =Z!UHQ11?4"0'BF-UI,T4( IZFF8HS1T <QIM%&*+Z *M/)XJ.C-#W .]
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M9@: V!1<&)WIQ7BFYYIQ8$4<P" 9H(Q2 XH+9HNA#@O%-[TX,,4TGFA,8N*
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M334@8;:C8\T6 *4+FFYJ1#0 TC%)3G-,S0 X<TI7%-4\U(S#%%@(Z*3-&>:
M'[.]--2!AMJ-CS0 4H7--S4B&@!I&*2G.:9F@!PYI2N*:IYJ1F&* (Z*3-&>
M: '[*::D##;4;'F@ IP7-,S4B&@!I&*2G.>:9F@!PYI2N*13S3V88H CHI,T
M9YH ?LIIJ0,-M1L>:+ %."YIF:D0T -(Q24YSS3,T *!FG%<4BGFGLPQ18!@
M&:0TJFD)YI-BZCMO%)CFG!AMIN>:2&PQB@#-#&E0T@0A&*7;0QYHWC%-[ -Q
M1MQ2@\TXG(I@,HI*4<TP%Q32,U*!Q2!.:+"1"$VT]>:G,6X4J6YS0,C6/-3)
M:D]JL10<]*OQ1 #I0!12UQVJW%%CM5D(/2EP*=P$"XIU%%( HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** &LN:J2V22=15VBG<5C$GT:
M%U/RBL*]\/Q$'""NW(R*K26P?M5QFT0XW/*=2\.KSB.N4OO#K<XCKW2;2DDZ
M@50E\.QO_"*W5>QFZ9\\7>@3!CA#6;+HLRC[AKZ)N/"<+ G8/RK#O/"L8S\@
M_*M(U[D.%CP*72I@?NFJSZ=,O\)KVRX\+)D_(/RK*N?#*C/R?I6JJ"Y3R,V<
MH[&D^S2#M7HT_A['\'Z5GRZ$1_!^E5[0+'#_ &=_2E\A_2NO.BMG[A_*F/HS
M8^Y^E/V@N4Y+R7]*7R']*ZE=';/W#^5/_L9O[GZ4>U%8Y/R7]*/);TKK/[&;
M^X?RIG]CON^X?RH]J-*YRWDOZ4>2_I76'1FV_<_2FIHS9^X?RH]J/E.5\E_2
MC[.Y[5U3Z,V?N'\JLP:(Q7[GZ4.KH+E.,^S/Z4Y;>3TKM#H9S]S]*=_89 ^Y
M^E+V@<IQ36S^E(+9_2NU&B,3]S]*#H9'\'Z4.H+E.*-M)GI3OLSXZ5V8T,D?
M<_2D_L1L_<_2A5 Y3B_LTF>E*;9_2NU.AG&=GZ4@T-B?N?I0Z@<IQ:VS^E(;
M9\]*[4Z(1_!^E*-#)'W/TH]H'*<5]F?'2D%M)GI7:?V(V?N?I3CH9Q]S]*7M
M+!RG%-;/Z4@MG]*[4:(3_!^E#:&1_!^E-U Y3BC;29Z4[[,^.E=F-#./N?I2
M?V(V?N?I0J@<IQ?V:3/0TIMG]*[4Z&<?<_2D&AD_P?I2=0.4XM;9_2D-L^>E
M=J=$(_@_2E&ADC[GZ4_:!RG%?9GQTI!;29Z5VG]B-G[GZ4XZ&<?<_2E[2P<I
MQ36S^E(+9_2NU&B$_P 'Z4-H9'\'Z4W4#E.*-M)GI3OLSXZ5V8T,X^Y^E)_8
MC9^Y^E"J!RG%BVDST-*;9_2NU.AG'W/TI%T,G^#]*.<.4XM;9_2D-L^>AKM3
MH;#^#]*4:&2/N?I3]H'*<5]F?'2D%M)GI7:?V(<_<_2G'0R!]S]*2F'*<4UL
M_I2"V?TKM1HC'^#]*&T,C^#]*'4#E.*^S29Z4[[,^.E=H-#./N?I2?V(V?N?
MI350.4XH6TF>E*;9_2NU.AG'W/TI%T,G^#]*7.'*<6ML_I2&V?/2NU.AL/X/
MTI1H9(^Y^E/V@<IQ7V9\=*06TF>E=I_8C9^Y^E..AD#[GZ5/M+!RG%-;/Z4@
MMG]*[5=#)_@_2AM#(_@_2FZ@<IQ1MI,]*=]F?'2NT&AG'W/TIO\ 8C9^Y^E"
MJ!RG%BVDSTI3;/Z5VIT,X^Y^E(-#)_@_2AU Y3BUMG]*0VTF>AKM3HC#^#]*
M4:&2/N?I1[0.4XK[,^.E(+:3/2NT_L1L_<_2G'0R!]S]*7M+!RG%-;/Z4@MG
M]*[5=#)_@_2AM#(_@_2FZ@<IQ7V:3/2G?9GQTKM!H9Q]S]*;_8C9^Y^E"J!R
MG%BVDST-*;9_2NU.AG'W/TI!H9/\'Z4.H'*<6+9^XI#;29Z&NU.B,/X/TI1H
M9(^Y^E'M Y3BOLSXZ4@MI,]*[3^Q&S]S]*4Z&<?<_2E[2P<IQ;6S^E(+9_0U
MVJZ&3_!^E!T,C^#]*;J!RG%?9I,]*=]F?'2NT&AG'W/TIO\ 8C9^Y^E"J!RG
M%BVDSTI3;/Z5VIT,@?<_2D70R?X/THYPY3BQ;/Z4C6TGH:[4Z(1_!^E+_89(
M^Y^E/V@<IP_V:3TIPMI/2NS_ +#.?N?I3CH9 ^Y^E)U!V.*:U?TIOV5_2NW7
M0R?X/TH;0SG[GZ4XS%RG%"VD]*=]E?'2NT70C_<_2G?V&?[GZ4W4$T<,;:3T
MIC6TGI7<MH1_N?I3!H1/\'Z5*JZEQB<1';2>8#BO0_"+R1SQBJ?]A$,/D_2N
MET#36BN$^7O6-9W1HEJ>W>'VS8)GTK8K%T(%+-![5LCI7"T;H6BBBI&%%%%
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M2K_V89I_DB@"G#%SR*L^2/2I5C J3% $21@5*!B@"EH **** "BBB@ HHHH
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MP?I7H'E+Z4>4OI1[1AR'GY\**?X/TI?^$47^Y^E=_P"4OI1Y2^E'M&'(>?\
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MO*J?%% $2IBI *6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *,444 %%%% "8I:** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
IHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  X &H# 2(  A$! Q$!_\0
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M7YI&QC+'N<5T5O#';QB.)=JC]:52KSZ)6'"'*24445D6%%%% !1110 4444
3%%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
